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ABSTRACT
FACTORS ASSOCIATED WITH ADULTS’ PERCEPTIONS OF NICOTINE AND
NICOTINE E-LIQUID HARM TO YOUNG CHILDREN AND ASSOCIATIONS WITH
NICOTINE HANDLING BEHAVIORS IN THE HOME
By
CATHERINE BLANCHARD KEMP
JULY 31, 2018
Electronic nicotine delivery systems (ENDS) use has grown rapidly over the past decade.
ENDS-specific harms have emerged among children (particularly those < 6 years), related to
exposures to nicotine e-liquids (NEL) used in ENDS. Children have been identified as a priority
population in terms of the potential and actual NEL-caused harm in the United States (US).
Evidence is lacking examining contextual factors such as adults’ risk perceptions related to child
NEL exposures and how these materials are handled in homes where children are present.
Guided by the Protection Motivation Theory (PMT), this dissertation focuses on adults’ risk
perceptions of children’s exposure to nicotine and NEL handling practices in the home.
Study 1 examined risk perceptions related to children’s (< 13 years) exposure to nicotine
generally (not product-specific) among a representative sample of US adults, and found that
current tobacco product users, males, and persons from racial/ethnic minority backgrounds were
significantly less likely to perceive nicotine as harmful to children. Study 2 examined risk
perceptions related to children’s (< 6 years) exposure to NEL in two dose-levels by five exposure
modes, among adults who lived with at least one child (< 6 years) and were ENDS users, nonusers living with a user, or never-users in never using homes. Study 2 found that ENDS-users
were significantly less likely (versus never users from never-user homes) to perceive NEL
exposure as moderately or very dangerous in 7/10 of dose/mode dyads examined. Study 3
examined relationships between perceptions of NEL-related risk to children and NEL handling
practices among adult ENDS-users and non-users living in ENDS using homes who also had a
child (< 6 years). This study found that being a non-user was significantly associated with not
knowing about the NEL handling practices in their home, and perceiving child NEL exposure as
very dangerous was significantly associated with always using childproof caps.
These findings highlight the need to educate adults about nicotine’s harmfulness to
children and to develop measures to protect children from nicotine and NEL exposures.
Opportunities to improve all adults’ NEL-related knowledge to improve safety for children are
also discussed.
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Introduction
Patterns of tobacco product consumption in the United States (US) have been changing
dramatically in recent years.1 For example, from 2000 to 2015 while consumption of noncigarette combustible tobacco (e.g., cigars and pipe tobacco) increased by 117.1% and use of
smokeless tobacco products (snuff and chewing tobacco) increased by 23.1%, Americans’ total
consumption of cigarettes declined by 38.7%.1 In addition, use of electronic nicotine delivery
systems (ENDS; e.g., e-cigarettes) among both adult1-4 and adolescent 5-9 populations has
steadily increased since these products were first marketed in the U.S. in 2007.2,3 More than a
fifth of American adults have used ENDS to consume vaporized nicotine,4 and most ENDS users
also smoke combustible cigarettes (commonly referred to as dual use).4,10-12
Among Americans who have ever smoked cigarettes, 38.2% of current smokers and
49.3% of recently former smokers have used ENDS.13 While use of ENDS has grown steadily
among all age groups in the U.S. in recent years, it has grown more rapidly among adults 18-44
years.14,15 Furthermore, research indicates that 40% of American ENDS users aged 18-24 years
had never smoked cigarettes.16 It is unclear whether or how never-smoker ENDS users’
knowledge and risk perceptions of nicotine might differ from that of smokers who may have
more experience using nicotine products.
ENDS are devices in which battery-powered heating coils aerosolize liquids containing
propylene glycol or vegetable glycerin as the suspending agent along with food-grade flavorings
and varying amounts of nicotine17-19 for inhalation. The two most commonly used ENDS are ecigarettes (prefilled, sealed, disposable units)19,20 and refillable vaporizers20-25 (“vapes”; open
systems with refillable tanks or replaceable cartridges that are the reservoirs for the eliquid19,20,26). The range of ENDS products is constantly evolving with increasing diversity and
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technological sophistication.27 Over this rapid evolution unanticipated consequences have
emerged, such as nicotine toxicity among children resulting from exposures (by ingestion and
dermal contact) to the flavored e-liquids. Data from the GSU TCORS annual Tobacco Product
Use and Risk Perception Survey indicate that in 2016, slightly more than a third of U.S. adults
who had ever used ENDS (34.6%; 95% CI: 30.9% - 38.2%) and of current ENDS users (36.0%;
95% CI: 30.0% - 42.0%) had at least one minor child living in their home (unpublished analysis
performed by CBK).
Current evidence indicates that ENDS-use is most likely safer than smoking combustible
cigarettes28-33; this should not be construed that ENDS are harmless.34 The nicotine e-liquids
(NEL) used in ENDS are described by proponents of vaping as “safe” because they contain
widely-used ingredients such as propylene glycol and food-grade flavorings.35 Despite growing
enthusiasm for the potential of ENDS as smoking cessation tools,36 more research is needed to
evaluate the validity of such claims.37-46 This enthusiasm, coupled with the tendency to view
potential ENDS-associated harms in relation to the harms of combustible tobacco use, has
contributed to under-recognition of and inaccurate perceptions of ENDS-specific harms such as
nicotine toxicity from ingestion or transdermal/mucosal exposure to nicotine e-liquids,
particularly among children.29,30 The need for knowledge regarding child exposure to nicotine
contained in novel tobacco products and how the availability of these products affect nonsmoking populations has been discussed by clinical,29,30 ethical,47 and regulatory policy48
scholars.
Exposure to NEL (by ingestion and dermal absorption) has resulted in a variety of
clinical consequences in the U.S., ranging from acute gastro-intestinal illness with full recovery
to death.49-52 Nicotine concentrations in NEL vary widely. Laboratory studies have found wide
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variance between labeled and actual levels,53,54 making it difficult to determine ingested doses
accurately. Nicotine exposure during fetal, infant, and childhood development has been
associated with a range of neuro-cognitive and developmental disorders.55
Oral nicotine doses of 10 mg. in children and 30-60 mg. in adults are considered lethal.56
NEL are typically sold in 15 ml bottles; with the recommended nicotine concentrations of 6
mg/ml (0.6%) for light to intermediate smokers, 57,58 the amount of nicotine contained in one 15
ml bottle of NEL could be a fatal to an adult or a child.29,56 However, in a recent review of the
supporting evidence for these estimated lethal doses, Mayer points out that these estimates may
be dubious and actual cases of lethal nicotine ingestion are rare.59 Despite questions regarding
nicotine’s actual lethal oral dose, there is growing evidence in the literature of acute severe
illness associated with ingestion of nicotine NEL by children.30,50,51,60-66 In addition,
neurodevelopmental, metabolic, and cognitive disorders emerging during childhood and
adolescence have been associated with nicotine exposure during fetal30,62,67-79 and early
childhood30,75-77,80 development.
Research regarding risk perceptions about nicotine has generally focused on its
addictiveness, with some recognition that nicotine exposure may be harmful to developing
fetuses.28,81,82 Furthermore, studies have generally focused on inhaled nicotine from second- or
third-hand (nicotine accumulation on surfaces in environments where smoking has taken place)
exposure. This lack of recognition of potential harms of nicotine to children may have
contributed to the almost 15-fold increase in calls to the National Poison Data System between
2012 and 2015 regarding childhood nicotine NEL exposures.50 Of particular concern, children
ingesting nicotine NEL have been shown to have a more than five times greater likelihood of
receiving inpatient treatment and more than double the likelihood to have a severe outcome,

12

compared to those who ingest materials in traditional cigarettes.50 One death of a child resulting
from nicotine ingestion was documented in the U.S. between January 2012 and April 2015.50
Concerns over NEL-related childhood nicotine exposures resulted in Congress approving
the Child Nicotine Poisoning Prevention Law83 (CNPP) which became effective in July 2016 and
mandates childproof packaging of nicotine-containing e-liquids. The CNPP gives authority to the
Consumer Product Safety Commission (CPSC) to test whether the packaging is childproof under
CPSC’s existing guidelines.84 The test involves a two-step procedure in which children, aged 4251 months, are given two sequential opportunities of 5 minutes each to open a “childproof”
container after all tamper-resistant packaging has been removed.85 I have been unable to find any
information regarding enforcement and/or compliance with the CPSC regulations in relation to
nicotine e-liquids.
The ‘deeming rule’ refers to a set of regulatory actions taken by the U.S. Food and Drug
Administration (FDA) in 2016 in which the agency asserted its tobacco regulatory authorities to
non-cigarette tobacco products such as ENDS and NEL.86 Enforcement deadlines for ENDS
product regulations under the deeming rule were extended in late 2017, to as far as August 2022,
although none are specific to child-resistant packaging.87
Although there was an approximately 20% reduction in the number of NEL exposures
reported monthly in the year following CNPP’s enactment, several hundred such exposures
continue to be reported monthly in the US.88,89 There are published and proposed regulations
under the deeming rule90 that will address some aspects of nicotine-containing NEL safety;
however, many of these will not go into effect for several years87 and they do not specifically
target issues related to children being exposed to nicotine e-liquids. For example, the
requirement for health warning labels to be applied to nicotine-containing bottles and other
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vessels requires the label to state: ‘WARNING: This product contains nicotine. Nicotine is an
addictive chemical’’90 (p.7). There is currently no provision mandating any warning pertaining to
the toxicity of nicotine when ingested or absorbed through the skin or mucous membranes, nor
its particular toxicity to children.90 This underlines the need for better understanding of
childhood nicotine exposure-related risk perceptions held by tobacco product users and adults
who live with them and the need for interventions to educate them on the dangers of childhood
nicotine exposure and how to prevent it.
NEL typically contain food-grade flavorings that can be tasted when in contact with taste
buds; many of these flavors are appealing to children (e.g., fruit and candy flavors).8,91 I have not
found any published research describing factors related to the packaging of flavored NEL that
might be especially appealing to young children (6 years old and younger), or effectiveness of
mandated child-resistant packaging. There is evidence from research involving adolescents
indicating that visual depictions of NEL flavorings are associated with increased interest in
trying ENDS.92,93
One published study94 examined parents’ risk perceptions and risk factors of exposure of
children to NEL in the home environment. A convenience sample of parents (N = 658) bringing
children to scheduled appointments at a multisite pediatric practice in St. Louis, Missouri were
surveyed over a two-month period in 2015. That study found that while almost three-quarters
(74%) of the 73 parents who reported e-cigarette use in the home felt it would be “very
dangerous” if their child swallowed the e-liquid, 36% neither stored the NEL in locked spaces
nor used child-proof caps, 19.7% only used child-proof caps, 8.2% reported only locking up the
e-liquids, and 31.1% reported that they both used child-proof caps and stored the bottles in a
locked space. These findings offer important insights, but the generalizability may be limited due
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to the relatively small sample size and restricted sampling frame, and they have yet to be
replicated (to my knowledge).
Statement of Purpose
Regardless of whether ENDS are effective as smoking cessation aids or how they are
marketed, it is important to communicate that these products are not free of risks50,51,60,63,64,66,95
and to provide evidence-based guidance on appropriate precautions. Effective mitigation to
reduce the risks of exposure to children in households where ENDS products are used will
require a multifaceted approach involving several different target populations (including adults
in the general population, adults who use ENDS products and have children in their homes, and
adults who live in homes where another person uses ENDS products and child(ren) also live).
The first step in this mitigation process will be to assess the knowledge and risk perceptions
related to childhood nicotine exposures held by each of the target populations to inform the
development of future mitigation interventions and policies.96,97
Such a multifaceted approach to reducing the risk of children being exposed to nicotine
from novel tobacco products such as ENDS will (hopefully) result in more effective and efficient
targeted interventions. It will support the goal of reducing one of the identified principle sources
of ENDS-related harm to this at-risk priority population34 by improving safe NEL handling
broadly, and specifically in homes where ENDS products are used.
The research presented in this dissertation was theoretically informed by the Protection
Motivation Theory (PMT),98,99 a framework which proposes that a person’s coping with a health
threat is informed by two processes: their assessment of the threat and assessment of the options
available to them to cope with the threat.98-103 Development of the survey instrument used in
Study 2 and Study 3 was guided by the PMT constructs of perceived vulnerability and perceived
severity of the threat appraisal process and the response efficacy and self-efficacy of the coping
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methods process,101,103 as illustrated in Figure 1. PMT was developed by Rogers98 to provide a
framework for conceptualizing fear appeals. This conceptual framework is well-suited for
research related to caregiver behaviors to protect children from harm; PMT has been used in
previous research to model home safety of small children104 and injury prevention among
children working on family farms.105 In these studies,104,105 protection motivation was
hypothesized to be invoked when parents perceive their child to be under threat of injury. In a
similar fashion, the perceived threat of harm to the child from NEL exposures was assessed in
Study 2. The relationship between this perceived threat of NEL exposure-related harm to the
child invoking the adult’s protective behavior to prevent NEL exposures to the child was
modeled in Study 3.
Figure 1. Graphic depiction of Protection Motivation Theory (PMT) applied to the context
of the research presented in this dissertation.

Chapters 2, 3, and 4 of this dissertation document present the dissertation research
performed in manuscript format. Study 1, presented in Chapter 2, examines adults’ risk
perceptions of children (<13 years) being exposed to nicotine in general (not by specific product
type), stratified by current tobacco product use and controlling for demographic characteristics in
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a large, nationally representative sample. Study 2 examines adults’ risk perceptions of specific
doses and modes of NEL exposure to children aged six years and under in relation to current
ENDS use (current user, lives with a current user, or no-one in the house has ever used ENDS),
controlling for demographic characteristics in a convenience sample of U.S. adults. Study 3
builds on Study 2 by examining relationships between risk perceptions of children (< 6 years)
being exposed to NEL and NEL practices in the home, controlling for current ENDS use (current
user or lives with a current user) and demographic characteristics in a convenience sample of
U.S. adults. Chapter 5 summarizes the findings of these three studies and discusses implications
for future research.
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Chapter 2:
Published Manuscript, Study 1: Adults’ Perceptions of Nicotine Harm to Children
Embedded PDF: Kemp, C. B., Spears, C. A., Pechacek, T. F., & Eriksen, M. P. (2018). Adults’
Perceptions of Nicotine Harm to Children. Pediatrics, 142(2).106
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Table of Contents Summary
We examined adults’ harm perceptions of child exposures to nicotine e-liquids used in electronic
vaping products (EVP) at two doses, by five modes of exposure.
What’s Known on This Subject
EVPs are increasingly being used by adults as a “safe” alternative to smoking. Flavored,
nicotine-containing e-liquids in EVPs typically have high nicotine concentrations. Instances of
children being exposed to them have increased in recent years, with sometimes severe
consequences.
What This Study Adds
Among the first which specifically examines adults’ perceptions of nicotine e-liquid harms to
children, this study found that EVP users have lower estimates (versus non-users) of potential
harms to children across modes and doses of exposure.
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Abstract
Background
Acute childhood nicotine exposures result in clinical presentations ranging from mild illness to
death. United States (US) nicotine e-liquid (NEL)-related cases of childhood nicotine toxicity
have risen sharply in recent years.
Methods
US adults (>18 years, n=611) were surveyed via Amazon MTurk in April 2018. All participants
lived with a child (<6 years), and either: currently used nicotine-containing electronic vapor
products (EVP); were not EVP users, but lived with an adult current EVP user; or lived in a
never-EVP using home. Risk perceptions of children’s (<6 years) exposure to five modes (lips,
nose, eyes, skin, swallowing) at two NEL doses were elicited. Binomial descriptive and x2
statistics characterized the sample; multinomial regression analyses examined relationships
between respondent characteristics and perceived NEL harm to children.
Results
Non-EVP user respondents characterized NEL exposure as ‘moderately’ or ‘very’ dangerous to
children across all exposure dose/mode dyads examined. Current users had significantly lower
odds of perceiving similar risks in the majority of modes examined; for example, they had
significantly lower odds of characterizing a teaspoon or more of NEL as ‘very dangerous’
(ORadj:0.4; 95%CL:0.1,0.9) in a child’s nose, or “moderately dangerous” (ORadj:0.5;
95%CL:0.3,0.9) on a child’s skin.
Conclusions
These results raise concern about lack of knowledge of the health risk of children’s exposure to
NEL; they underscore the need to better understand how these products are used, handled, and
stored in the presence of children. Interventions are needed to protect children from NEL
exposure and educate users of these products.

45

Introduction
There has been a proliferation of non-cigarette tobacco products in the United States (US)
market over the past decade,1 providing new sources of nicotine consumption for adults and
unintended exposures to children. Ever-use of electronic vapor products (EVP), a type of noncigarette tobacco product, increased significantly among US adults in recent years.2 EVPs
approximate the smoking experience3 by aerosolizing liquid suspensions (‘e-liquids’) that
typically contain varying amounts of nicotine, propylene glycol, glycerin, food-grade flavorings
and other additives for inhalation.4 While many smokers view EVPs as smoking cessation aids5,
their efficacy in this regard is unclear.5-11 The Centers for Disease Control and Prevention
estimates that in 2016, 15.4% of US adults had ever used EVPs and 3.2% were current users.12
Childhood nicotine toxicity resulting from exposures to nicotine e-liquids (NEL) used in
EVPs is of particular concern.13 NEL were second only to cigarettes as a source of unintended
childhood nicotine exposure in the US in recent years.13,14 While EVPs use may be less harmful
for adults versus smoking cigarettes,15,16 NEL exposure (by ingestion and skin/mucous
membrane contact) has been highlighted as a principle reason for the 1500% increase in tobacco
product-related calls to the National Poison Data System between 2012 and 2015.13,17 Children
ingesting NEL are five times more likely to require hospitalization and more than twice as likely
to have a severe outcome, compared to children ingesting conventional cigarette materials;13
NEL ingestion has resulted in clinical presentations ranging from acute gastrointestinal illness to
convulsions, altered consciousness, and death.13,18-20 Although the nicotine human oral fatal dose
(LD-50) of 60 mg for adults and 10 mg for children are commonly cited, the origins and
objective evidence supporting these guidelines are unclear.21,22
A 2016 US federal law mandated childproof packaging for NEL,23 resulting in an
approximately 20% decrease in overall reports of NEL exposures to the American Association of
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Poison Control Centers’ (AAPCC) hotlines following the law’s enactment.24,25 However, several
hundred NEL exposures continue to be reported to AAPCC monthly. Calls to AAPCC seeking
information regarding identified exposures is a crude measure and likely underestimates the
actual number; at present it is the only national exposure tracking metric available in the US.26
The persistence of this problem following statutory regulation underscores the need for
additional efforts such as: educational interventions to inform EVP users and the people who live
with them about the dangers of NEL for children; development of guidelines for safe handling
and storage of NEL; and Public Health (PH) messaging about appropriate interventions to
manage childhood nicotine exposures. Given the lack of reliable epidemiologic data
documenting rates and outcomes associated with nicotine toxicity in humans, a systematic
mechanism to track such exposures would be helpful. The latter information is particularly
important with the ever- increasing number of sources of nicotine exposure in the public
marketplace.
Research documenting adults’ risk perceptions regarding young children’s exposure to
NEL is very limited. The authors of one published study27 examined some of these issues
specifically related to EVPs among parents of child patients in an urban pediatric practice.
Although most parents in this study believed that children’s ingestion of NEL would be
dangerous, less than a third thought skin contact would be dangerous. Many EVP-using parents
in that study did not have adequate knowledge about nicotine-specific harms to children, and
NEL safe-storage practices were inconsistent.27 Authors of another published study28 reported
analyses of a nationally representative survey of adults’ risk perceptions of children’s harm from
nicotine exposure generally (not EVP-specific). Results indicated that specific population
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subgroups (including current tobacco product users, males, and persons from racial/ethnic
minorities) tended to perceive lower harmfulness of nicotine to children.
Because NELs have become an important source of children’s exposure to nicotine in
recent years, research is needed to assess adults’ risk perceptions of NEL causing harm to
children, and how perceptions covary with different exposure doses and modes (e.g., swallowing
vs. skin contact). Such research should include not only EVP users, but also other adults who
live with them and are responsible for providing a safe environment for the children in the home.
Thus, the current foundational study sought to: 1) document the risk perceptions of US adult
EVP-users and non-users who live in a home with at least one child (<6 years); and 2) examine
whether demographic and/or behavioral factors (e.g., level of education, EVP-use status) are
related to perceptions of nicotine harm to children.
Methods
Sample
Data were obtained via an online survey administered on the Amazon Mechanical Turk
Platform (MTurk) during April 2 and 3, 2018. MTurk is a crowd-sourcing platform that provides
researchers with an efficient, diverse, and easily accessible pool of respondents.29-32 Samples
drawn from MTurk are not demographically representative of the US adult population.29 During
this study’s data collection period, the MTurk worker pool demographics were, on average:
56.7% female, 83.3% in a household of four or fewer people, 41.3% married, and 12%
cohabiting;33 information regarding number and ages of children in the households, and the
racial/ethnic distribution in the pool were not available.
Eligibility criteria for this study included: aged 18 years and older, current US resident,
lives in a home with at least one child (aged <6 years), and either: currently uses EVP, lives with
another adult current EVP-user, or no adult in the home has ever used EVP. The study protocol
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was reviewed by the Georgia State University (GSU) Institutional Review Board and determined
to be exempt. Participants were paid $2 for their responses, which were completed in an average
of 9 minutes.
Measures
Socio-Demographics
Age (‘18-34 years’ and ‘35 years and older’), sex, education (‘some college or less’ and
‘Bachelor’s degree or higher’), race/ethnicity (‘White non-Hispanic’ and ‘Black non-Hispanic,
Hispanic, or Other’), and relationship to the youngest child (‘parent or parent figure’ and ‘other
relative or cohabiting’) residing in the home were assessed.
EVP use
Participants were asked about the current use of EVP in their homes. Those who
described either themselves or another adult living with them having used EVP in the preceding
30 days or stated that no adult living in their home had ever used EVP were included. Adults
who were or lived with an EVP-user were also asked, “Do the e-liquids that are vaped
in electronic vapor products in your home usually contain nicotine?”; those responding ‘yes’ or
‘I don’t know’ were included, while those responding ‘no’ (n = 44) were excluded.
Perceptions of Nicotine-related Harm
With no existing measures to study adults’ perceptions of NEL harm to children, we
consulted with experts from GSU’s National SafeCare Training Center
(https://safecare.publichealth.gsu.edu/) and GSU Tobacco Center of Regulatory Sciences
(https://tcors.publichealth.gsu.edu/ ) to inform construction of the survey instrument. To elicit
perceptions of NEL harm to children, participants were asked (for example): “How dangerous do
you think it would be for a child (6 years old or younger) to swallow 1 or 2 drops of e-liquid?”
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Versions of this question were asked for two different doses (“1 or 2 drops” and “a teaspoon or
more”) of e-liquid for each of the following exposure types: skin contact, on the lips, inside the
nose, in the eye, and swallowing. Response options included: ‘very dangerous,’ ‘moderately
dangerous,’ ‘minimally or not dangerous at all,’ and ‘I don’t know.’ The ‘I don’t know’
responses accounted for 1-4% of total responses and were excluded from the analyses.
Measure of Social Desirability
The Social Desirability Response Scale (SDRS)34 was incorporated into the study survey
questionnaire due to the nature of the survey’s focus on nicotine harms to children. The SDRS is
a brief measure of tendency towards socially desirable responses consisting of five items;35 it has
been evaluated in a number of different settings and cultures and found to have a high degree of
reliability and internal consistency.34,35 The items were scored “1” to “5”, with a mean composite
score close to 5 representing a tendency towards responding in a socially desirable manner.
Data Analysis
Univariate and bivariate frequencies, chi-squared (x2) tests, and multinomial logistic
regression analyses were performed using SAS software, version 9.4 (©2012, The SAS Institute,
Cary, NC). Descriptive statistics and x2 tests evaluated the demographic characteristics and
responses to the NEL harm to children risk perception responses of the total sample and by their
EVP use status; patterns of significant associations among the independent variables (IV) and
between the IV and dependent variables (DV) were examined using x2 tests to inform the model
building process. Multinomial logistic regression was utilized to examine adjusted relationships
between the IVs and DVs.
Results
The univariate demographic and bivariate by EVP-use status frequencies are presented in
Table 1. Except for highest level of education completed and categorical age, all demographic
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variables were significantly associated with EVP-use status. In addition, EVP-use status was
significantly associated with perceptions of child (<6 years) NEL exposures in all combinations
of dose levels and exposure modes. EVP users in this sample were significantly more likely to be
male (p < .0001).
PLACE TABLE 1 HERE
Results of the multinomial regression models (Tables 2-5, Supplemental Table S1)
demonstrated that current EVP users had significantly lower odds (versus adult never-EVP users
in never-EVP using homes) of responding that children (<6 years) being exposed to NEL was
‘moderately’ or ‘very’ dangerous in seven out of ten of the dose/exposure-mode dyads examined.
For example, EVP users had significantly lower odds (versus adults from homes of never-EVP
users) of perceiving the following doses/modes of NEL contact as very dangerous to a child (<6
years): A teaspoon or more: in the nose (ORadj:0.4; 95%CL: 0.1,0.9); 1 or 2 drops: on the skin
(ORadj:0.5; 95%CL: 0.3,0.9), in the nose (ORadj:0.4; 95%CL: 0.2,0.7), on the lips (ORadj:0.5;
95%CL: 0.2,0.8), and swallowed (ORadj:0.5; 95%CL: 0.3,1.0). The only dose/exposure-mode
dyads in which none of the current EVP users’ perceptions of nicotine harm to children (<6
years) differed significantly from those of adults from never EVP-use homes was in both doses
of eye contact (Supplemental Table S1).
PLACE TABLE 2 HERE
PLACE TABLE 3 HERE
PLACE TABLE 4 HERE
PLACE TABLE 5 HERE
In addition, males had significantly lower odds (versus females) of perceiving NEL
exposure by swallowing 1 or 2 drops (Table 5) as “very dangerous” to children (<6 years), and a
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teaspoon or more of NEL exposure on the skin (Table 4) as “very dangerous” to children (<6
years). Adults 34 years old and younger had significantly lower odds (versus adults 35 years old
and older) of perceiving a teaspoon or more of NEL in the nose contact as being “moderately
dangerous” or “very dangerous” (Table 3), and perceiving skin contact exposure of a teaspoon or
more of NEL as “very dangerous” to children 6 years and younger (Table 4).
The sample composite mean SDRS score of 1.08 (95%CL: 0.97,1.18) indicated a lack of
tendency towards responding in a socially desirable (rather than objective) manner among the
sample.
Discussion
This study analyzed US adults’ perceptions of different doses and modes of NEL
exposures being dangerous to children (<6 years) in a sample of US adults who were either
current EVP-users, non-users who lived with a current EVP-user, or never-users living in a
household of never-EVP users. Findings indicate that while the majority perceived all NEL
exposure dose/mode dyads as “moderately” or “very” dangerous to children, current EVP users
had significantly lower odds of endorsing such perceived harm in the majority of doses/mode
dyads examined. This study also found that males and younger adults had significantly lower
odds of perceiving some NEL exposure dose/mode dyads as being “moderately” or “very”
dangerous to a child (<6 years). Interestingly, adult non-users living with an EVP-user
demonstrated patterns of responses very similar to adult never-EVP users living in never EVPusing homes.
The findings that EVP users had lower odds of perceiving NEL exposure as being
moderately or very dangerous to children (<6 years) in the majority of dose/mode dyads
examined are a particular cause for concern, given that (presumably) EVP users have the most
control over the source of NEL exposure in the home. EVP use has grown among current and

52

former smokers, as well as those who have never smoked cigarettes in the US.2,36 This trend is
expected to continue as more of these products are developed and marketed37 and national
policies are enacted to continue downward pressure on smoking rates, leaving smokers to
consume nicotine by alternative means such as EVPs.38,39
While EVPs might provide a less harmful alternative to smokers under certain
circumstances,40 they have become a leading source of harmful nicotine exposure to
children.13,14,18,25 Many of the food-grade fruit and candy flavors used in NEL are appealing to
children,41,42 and the products are marketed in a way that primarily promotes their flavors.41-45
Furthermore, the packaging of some NELs emphasize fruit or candy flavors and can closely
resemble popular branded candy packages46 (for example, see Figure 147), leading the FDA (in
conjunction with the Federal Trade Commission) to issue warning letters to a number of NEL
manufacturers in 2018.48
PLACE FIGURE 1 HERE
The number of cases of nicotine poisonings resulting from child exposures to NEL has
risen sharply in recent years.13,49 Although there was a 20% reduction in the number of reported
NEL exposures after national mandates for childproof packaging became effective in July 2016,
several hundred such exposures continue to be reported monthly in the US.49 While AAPCC data
provide some indication that nicotine exposures are occurring, more precise and accurate
epidemiologic data are needed to appreciate the true scope of this problem.
Our findings are similar to those of Garbutt et al.,27 who reported finding variations in
adults’ perceptions of risks of children being exposed to NEL by mode of exposure. However,
their study did not examine doses of exposure. The findings of the present study also build on
those of Kemp et al.,28 who reported that although adults generally (not specific to a product or
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mode of exposure) perceived child (< 13 years) exposure to nicotine as very harmful, current
tobacco product users (including EVP users), non-Hispanic African American individuals,
Hispanic individuals, and males had significantly lower odds of perceiving such harm. In the
current study, we similarly found that current EVP users and males had lower odds of perceiving
NEL exposures as “moderately” or “very” dangerous to children (<6 years); we did not have
similar findings based on racial/ethnic minority status. Thus, this study examining adults’
perceptions of nicotine harms to children (<6 years) at different doses and modes of exposure
and controlling for EVP-use in the home status, is the first (to our knowledge) of its kind. This
study provides important evidence of variations in risk perceptions among EVP users and adults
who live with them, some younger adults, and some males that may contribute to the risks of
children’s exposure to NEL, and subsequent harm.
Although this study’s restricted sampling frame (MTurk) limits the generalizability of its
findings, the consistency with which EVP users estimated less danger (versus EVP non-users) to
children (<6 years) from being exposed to different doses and modes of NEL suggests that these
findings could be replicated in a more general sample. Individuals from racial/ethnic minority
populations were underrepresented in our sample, a limitation of the MTurk sampling frame that
has been cited by other authors;30,32 this may have limited our study’s ability to detect differences
in adults’ risk perceptions by race/ethnicity. At a minimum, these results indicate that further
research in a more general sample of adult EVP users is needed to investigate how and why
adults’ perceptions of NEL harm to children vary. Research as to what actions are indicated to
better protect children from this exposure will be important as well.
This study was also limited by the lack of validated measures available to study adults’
perceptions of NEL harm to children. We attempted to address this limitation by drawing on the
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expertise of Tobacco Control and Child Safety experts when constructing the survey questions
and including different doses and modes of exposure.
This is one of the first studies examining aspects of adults’ perceptions of the risks that
nicotine exposure poses to children, in relation to demographic and/or EVP use characteristics.
The current findings provide important evidence of a need not only for further research, but also
for policy interventions and guidance for adults from EVP-using homes about the dangers of
children’s exposure to NEL. Pediatric care providers may be able to play an important role in
protecting children from NEL exposures and related harms by identifying those at risk and
educating the adults who live with them. Retailers could also be a valuable source to warn adult
users about the danger of leaving EVP liquids accessible to small children. While national NELspecific storage and handling guidelines have yet to be developed, measures such as ensuring
that containers have child-proof packaging, and handling and storing the materials in a secure
place out of children’s reach will likely be helpful in preventing such exposures and subsequent
harm to children.
Conclusion
Exposure to nicotine during critical child development periods has been associated with a
range of acute13,25,50,51 and chronic52,53 adverse clinical outcomes. NEL used in EVPs have
become a significant source, second only to cigarettes,24 of children being exposed to nicotine in
the US. Adults’ knowledge and perceptions of the risks posed to children by NEL exposure has
received scant attention in the literature. This study’s findings, that EVP users who live with a
child (<6 years) have significantly lower odds of characterizing NEL exposures as being
moderately or very dangerous to children across different doses and modes, is a cause for
concern. This finding provides important evidence for clinicians, policy-makers, and the
Tobacco Regulatory Science community. Further research of harm perceptions related to
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children’s exposure to NEL, and how those alter the way products are managed in the presence
of children, is needed to identify factors that put children at risk. Actions are needed to improve
safe NEL handling in homes were children are present.
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Table 1. Univariate and bivariate analyses of sample demographics and risk perceptions of children (< 6 years old) being
exposed to nicotine e-liquids at different doses and by different modes stratified by EVP use status (N = 611).
Univariate
% (95% CL^)
EVP use status

611 (100)

Bivariate By EVP_USE variable
EVP user
% (95% CL)

Never-user, lives
w/EVP user
% (95% CL)

Never EVP-use by
any adult in home
% (95% CL)

41.9 (38.0, 45.8)*

29.0 (25.4, 32.6)

29.1 (25.5, 32.7)

Relationship with youngest child in the home
Parent or parent figure
78.4 (75.1, 81.7)
75.8 (70.5, 81.0)
74.6 (68.1, 81.0)
Other relative or roommate of
21.6 (18.3, 24.9)
24.2 (19.0, 29.5)
25.4 (19.0, 31.9)
parent
Sex
Male
47.1 (43.2, 51.1)
59.0 (52.9, 65.0)*
38.4 (31.2, 45.6)
Female
52.9 (48.9, 56.8)
41.0 (35.0, 47.1)*
61.6 (54.4, 68.8)
Race/Ethnicity
White, NH
80.5 (77.4, 83.7)
78.5 (74.5, 83.6)
77.4 (71.2, 83.6)
African-American, Hispanic, or Other
19.5 (16.3, 22.6)
21.5 (16.4, 26.5)
22.6 (16.4, 28.8)
Categorical Age (Continuous-µ = 35.6, σ = 8.5)
18-34
52.9 (48.9, 56.8)
52.3 (46.2, 58.5)
54.2 (46.9, 61.6)
> 35
47.1 (43.2, 51.1)
47.7 (41.5, 53.8)
45.8 (38.4, 53.1)
Highest education completed
<=Some college
29.8 (26.1, 33.4)
34.0 (28.2, 39.8)
26.3 (19.7, 32.8)
>= Bachelor’s
70.2 (66.6, 73.9)
66.0 (60.2, 81.8)
73.7 (67.2, 80.3)
Perceptions of nicotine e-liquid harm to children by…
On the lips…
…1 or 2 drops
Very dangerous
43.0 (39.0, 46.9)
35.8 (29.9, 41.7)*
51.4 (44.0, 58.9)
Moderately dangerous
36.0 (32.1, 39.8)
35.0 (29.2, 40.9)
32.6 (25.6, 39.5)
Minimally or not dangerous at all
21.1 (17.8, 24.3)
29.1 (23.5, 34.7)*
16.0 (10.6, 21.4)
…A teaspoonful or more
Very dangerous
61.6 (57.7, 65.5)
57.2 (46.0, 58.4)*
68.6 (61.7, 75.5)
Moderately dangerous
29.1 (25.5, 32.8)
32.7 (26.5, 38.1)
26.3 (19.7, 32.8)
Minimally or not dangerous at all
9.3 (7.0, 11.6)
15.5 (11.0, 20.0)*
5.1 (1.9, 8.4)
In the nose …
…1 or 2 drops
Very dangerous
45.3 (41.3, 49.3)
34.9 (29.0, 40.8)
57.7 (50.4, 65.1)*
Moderately dangerous
37.1 (33.3, 41.1)
40.8 (34.7, 46.8)
29.1 (22.4, 35.9)
Minimally or not dangerous at all
17.2 (14.5, 20.6)
24.3 (19.0, 29.6)*
13.1 (8.1, 18.2)
…A teaspoonful or more
Very dangerous
65.8 (62.0, 69.6)
58.0 (52.0, 64.1)
72.0 (65.3, 78.7)
Moderately dangerous
25.1 (21.7, 28.6)
27.5 (22.0, 32.9)
24.0 (17.7, 30.3)
Minimally or not dangerous at all
9.1 (6.8, 11.4)
14.5 (10.2, 18.8)*
4.0 (1.1, 6.9)
In the eye…
…1 or 2 drops
Very dangerous
69.8 (66.1, 73.5)
63.1 (57.2, 69.1)
73.9 (67.4, 80.4)
Moderately dangerous
23.9 (20.5, 27.3)
27.8 (22.3, 33.4)
21.0 (15.0, 27.1)
Minimally or not dangerous at all
6.3 (4.3, 8.2)
9.0 (5.5, 12.5)
5.1 (1.9, 8.4)
…A teaspoonful or more
Very dangerous
81.3 (78.2, 84.4)
76.4 (71.1, 81.6)*
83.0 (77.4, 88.5)
Moderately dangerous
14.7 (11.9, 17.5)
16.9 (12.3, 21.6)
14.8 (9.5, 20.0)
Minimally or not dangerous at all
4.0 (2.4, 5.5)
6.7 (3.6, 9.8)*
2.3 (0.1, 4.5)
On the skin…
…1 or 2 drops
Very dangerous
19.3 (16.1, 22.4)
14.2 (9.8, 18.5)
22.9 (16.6, 29.3)
Moderately dangerous
38.0 (34.1, 41.9)
34.4 (28.5, 40.4)
39.4 (32.0, 46.8)
Minimally or not dangerous at all
42.8 (38.7, 46.8)
51.4 (45.2, 57.7)*
37.6 (30.3, 45.0)
…A teaspoonful or more
Very dangerous
36.4 (32.5, 40.3)
30.9 (25.1, 36.7)
42.8 (35.4, 50.2)
Moderately dangerous
36.4 (32.5, 40.3)
34.1 (28.2, 40.1)
34.7 (27.6, 41.8)
Minimally or not dangerous at all
27.1 (23.5, 30.7)
35.0 (29.0, 40.9)*
22.5 (16.3, 28.8)
Swallowing…
…1 or 2 drops
Very dangerous
56.9 (52.9, 60.8)
47.4 (41.3, 53.6)*
64.6 (57.5, 71.7)
Moderately dangerous
28.7 (25.1, 32.3)
34.0 (28.1, 39.8)
24.0 (17.7, 30.3)
Minimally or not dangerous at all
14.4 (11.6, 17.2)
18.6 (13.8, 23.4)
11.4 (6.7, 16.2)
…A teaspoonful or more
Very dangerous
76.9 (73.5, 80.2)
71.1 (65.5, 76.7)*
79.5 (73.6, 85.5)
Moderately dangerous
19.7 (16.5, 22.8)
22.9 (17.7, 28.1)
18.8 (13.0, 24.5)
Minimally or not dangerous at all
3.5 (2.0, 4.9)
5.9 (3.0, 8.8)*
1.7 (0, 3.6)
Abbreviations: ^CL: confidence limits.
*Indicates statistically significantly different from the reference category, ‘Never EVP-use by any adult in home’

(x2, df),
p-value
(20.2, 2) <.0001
(8.6, 2) .01

86.0 (80.8, 91.2)
14.0 (8.9, 19.2)
(24.8, 2) <.0001
38.8 (31.6, 45.9)
61.2 (54.1, 68.4)
(5.8, 2) .05
86.5 (81.5, 91.5)
13.5 (8.5, 18.5)
(.19, 2) .90
52.2 (44.9, 59.6)
47.8 (40.4, 55.1)
(3.8, 2) .15
27.1 (20.6, 33.7)
72.9 (66.3, 79.4)
(21.5, 4) .0003
44.8 (37.4, 52.2)
40.8 (33.5, 48.1)
14.4 (9.1, 19.6)
(25.6, 4) <.0001
68.0 (61.1, 74.9)
27.4 (20.8, 34.1)
4.6 (1.5, 7.7)
(24.7, 4) <.0001
48.0 (40.5, 55.4)
39.9 (32.6, 47.2)
12.1 (7.3, 17.1)
(24.3, 4) <.0001
70.9 (64.1, 77.6)
22.9 (16.6, 29.1)
6.3 (2.7, 9.9)
(24.7, 4) <.0001
75.4 (69.0, 81.8)
21.1 (15.1, 27.2)
3.4 (0.7, 6.1)
(11.9, 4) .02
86.9 (81.8, 91.9)
11.4 (6.7, 16.2)
1.7 (0.0, 3.6)
(14.9, 4) .005
22.9 (16.6, 29.3)
41.8 (34.3, 49.2)
35.3 (28.1, 42.5)
(15.5, 4) .004
38.0 (30.7, 45.3)
41.5 (34.1, 48.9)
20.5 (14.4, 26.5)
(16.5, 4) .003
62.9 (55.7, 70.0)
25.7 (19.2, 32.2)
11.4 (6.7, 16.2)
(12.2, 4) .02
82.4 (76.7, 88.0)
15.9 (10.5, 21.3)
1.7 (0.0, 3.6)
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Table 2. Multinomial logistic regression models regressing demographic and EVP-use characteristics on
adult’s perceptions of 2 different doses of EVP e-liquid nicotine on the lips causing harm to a child 6 years
and younger.
Model 2.1, On the lips contact with 2 or 3 drops
Model 2.2, On the lips contact with a
of nicotine e-liquid1,2
teaspoon or more of nicotine e-liquid1,2
Moderately
Very Dangerous
Moderately Dangerous
Very Dangerous
Dangerous
OR¥ (95% CL^)
Global test of null hypothesis [F(df);
1.8(14,543); .04
p]
EVP use status
EVP user
0.5 (0.3, 0.9)*
Never-user, lives w/EVP user
0.6 (0.3, 1.3)
Never EVP-use by any adult in home
ref
Relationship with youngest child in the home
Parent or parent figure
1.1 (0.6, 1.9)
Other relative or roommate of
ref
parent
Sex
Male
0.7 (0.4, 1.1)
Female
ref
Categorical Age
18-34
1.0 (0.6, 1.6)
> 35
ref

OR¥ (95% CL^)

OR¥ (95% CL^)

OR¥ (95% CL^)

2.7(14,543); .0008
0.5 (0.2, 0.8)*
0.9 (0.5, 1.8)
ref

0.3 (0.1, 0.7)*
1.0 (0.3, 3.0)
ref

0.4 (0.2, 1.1)
0.9 (0.3, 2.8)
ref

1.4 (0.8, 2.5)

1.1 (0.5, 2.5)

1.1 (0.5, 2.5)

ref

ref

ref

0.6 (0.4, 1.0)*
ref

0.3 (0.2, 0.7)*
ref

0.3 (0.2, 0.7)*
ref

0.8 (0.5, 1.3)
ref

0.9 (0.5, 1.9)
ref

0.7 (0.3, 1.3)
ref

Abbreviations: ¥OR: odds ratio; ^CL: confidence limits.
*Indicates statistically significantly different from the reference category
1
The dependent variable (DV) was assessed with the question: ‘How dangerous do you think it would be for a child (6 years old or younger) if [1 or 2 drops; a
teaspoon or more] of e-liquid got on their lips?’ The reference category for the DV is ‘Not or minimally dangerous’.
2
We adjusted for race/ethnicity and highest education completed in these models. Neither of these variables was significantly associated with the dependent
variables in any of the models examined, and therefore are not included in the results table.
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Table 3. Multinomial logistic regression models regressing demographic and EVP-use characteristics on
adult’s perceptions of 2 different doses of EVP e-liquid nicotine in the nose causing harm to a child 6 years
and younger.
Model 3.1, In the nose contact with 2 or 3 drops
Model 3.2, In the nose contact with a
of nicotine e-liquid1,2
teaspoon or more of nicotine e-liquid1,2
Moderately
Very Dangerous
Moderately Dangerous
Very Dangerous
Dangerous
OR¥ (95% CL^)
Global test of null hypothesis [F(df);
2.9(14,543); .0004
p]
EVP use status
EVP user
0.5 (0.2, 0.9)*
Never-user, lives w/EVP user
0.6 (0.3, 1.3)
Never EVP-use by any adult in home
ref
Relationship with youngest child in the home
Parent or parent figure
1.4 (0.8, 2.5)
Other relative or roommate of
ref
parent
Sex
Male
1.2 (0.7, 2.0)
Female
ref
Categorical Age
18-34
1.0 (0.6, 1.6)
> 35
ref

OR¥ (95% CL^)

OR¥ (95% CL^)

OR¥ (95% CL^)

2.7(14,543); .0009
0.4 (0.2, 0.7)*
1.0 (0.5, 2.1)
ref

0.5 (0.2, 1.3)
1.3 (0.4, 4.5)
ref

0.4 (0.1, 0.9)*
1.3 (0.4, 4.0)
ref

1.2 (0.6, 2.1)

0.7 (0.3, 1.7)

0.7 (0.3, 1.7)

ref

ref

ref

0.7 (0.4, 1.2)
ref

0.3 (0.1, 0.7)*
ref

0.2 (0.1, 0.5)*
ref

0.7 (0.4, 1.2)
ref

0.3 (0.2, 0.7)*
ref

0.3 (0.2, 0.7)*
ref

Abbreviations: ¥OR: odds ratio; ^CL: confidence limits.
*Indicates statistically significantly different from the reference category
1
The dependent variable (DV) was assessed with the question: ‘How dangerous do you think it would be for a child (6 years old or younger) if [1 or 2 drops; a
teaspoon or more] of e-liquid got in their nose?’ The reference category for the DV is ‘Not or minimally dangerous’.
2
We adjusted for race/ethnicity and highest education completed in these models. Neither of these variables was significantly associated with the dependent
variables in any of the models examined, and therefore are not included in the results table.
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Table 4. Multinomial logistic regression models regressing demographic and EVP-use characteristics on adult’s
perceptions of 2 different doses of EVP e-liquid nicotine on the skin causing harm to a child 6 years and
younger.
Model 4.1, Skin contact with 2 or 3 drops of
nicotine e-liquid1,2
Moderately
Very Dangerous
Dangerous
OR¥ (95% CL^)
Global test of null hypothesis [F(df);
2.2(14,556); .007
p]
EVP use status
EVP user
0.6 (0.4, 1.0)*
Never-user, lives w/EVP user
1.0 (0.6, 1.6)
Never EVP-use by any adult in home
ref
Relationship with youngest child in the home
Parent or parent figure
2.3 (1.4, 3.9)*
Other relative or roommate of parent
ref
Sex
Male
1.0 (0.7, 1.5)
Female
ref
Categorical Age
18-34
1.0 (0.7, 1.5)
> 35
ref

OR¥ (95% CL^)

Model 4.2, Skin contact with a teaspoon or more
of nicotine e-liquid1,2
Moderately
Very Dangerous
Dangerous
OR¥ (95% CL^)

OR¥ (95% CL^)

2.0(14,556); .02
0.5 (0.3, 0.9)*
1.0 (0.6, 1.9)
ref

0.5 (0.3, 0.9)*
0.7 (0.4, 1.4)
ref

0.6 (0.3, 1.0)
1.2 (0.6, 2.1)
ref

1.3 (0.7, 2.2)
ref

1.4 (0.8, 2.3)
ref

1.5 (0.9, 2.5)
ref

0.6 (0.4, 1.0)
ref

0.8 (0.5, 1.2)
ref

0.6 (0.4, 0.9)*
ref

0.7 (0.4, 1.2)
ref

1.0 (0.7, 1.6)
ref

0.6 (0.4, 1.0)*
ref

Abbreviations: ¥OR: odds ratio; ^CL: confidence limits.
*Indicates statistically significantly different from the reference category
1
The dependent variable (DV) was assessed with the question: ‘How dangerous do you think skin contact with [1 or 2 drops; a teaspoon or more] of e-liquid is for
a child (6 years old or younger)?’ The reference category for the DV is ‘Not or minimally dangerous’.
2
We adjusted for race/ethnicity and highest education completed in these models. Neither of these variables was significantly associated with the dependent
variables in any of the models examined, and therefore are not included in the results table.
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Table 5. Multinomial logistic regression models regressing demographic and EVP-use characteristics on adult’s
perceptions of swallowing 2 different doses of EVP e-liquid nicotine causing harm to a child 6 years and
younger.
Model 5.1, Swallowing 2 or 3 drops of
nicotine e-liquid1,2
Moderately
Very Dangerous
Dangerous
OR¥ (95% CL^)*
Global test of null hypothesis [F(df);
2.6(14,556); .001
p]
EVP use status
EVP user
0.8 (0.4, 1.8)
Never-user, lives w/EVP user
0.9 (0.4, 2.0)
Never EVP-use by any adult in home
ref
Relationship with youngest child in the home
Parent or parent figure
0.8 (0.4, 1.6)
Other relative or roommate of parent
ref
Sex
Male
0.9 (0.5, 1.6)
Female
ref
Categorical Age
18-34
0.7 (0.4, 1.3)
> 35
ref

OR¥ (95% CL^)*

Model 5.2, Swallowing a teaspoon or more of
nicotine e-liquid1,2
Moderately
Very Dangerous
Dangerous
OR¥ (95% CL^)*

OR¥ (95% CL^)*

2.4(14,556); .002
0.5 (0.3, 1.0)*
1.0 (0.5, 2.1)
ref

0.5 (0.1, 2.5)
1.3 (0.2, 9.8)
ref

0.2 (0.1, 1.3)
1.0 (0.1, 6.9)
ref

1.6 (0.8, 3.0)
ref

0.6 (0.1, 2.5)
ref

0.7 (0.2, 3.1)
ref

0.6 (0.3, 1.0)*
ref

0.6 (0.2, 2.1)
ref

0.4 (0.1, 1.5)
ref

0.7 (0.4, 1.2)
ref

0.9 (0.3, 2.7)
ref

0.6 (0.2, 1.6)
ref

Abbreviations: ¥OR: odds ratio; ^CL: confidence limits.
*Indicates statistically significantly different from the reference category
1
The dependent variable (DV) was assessed with the question: ‘How dangerous do you think it would be for a child (6 years old or younger) if they swallowed [1
or 2 drops; a teaspoon or more] of e-liquid?’ The reference category for the DV is ‘Not or minimally dangerous’.
2
We adjusted for race/ethnicity and highest education completed in these models. Neither of these variables was significantly associated with the dependent
variables in any of the models examined, and therefore are not included in the results table.
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Figure 1. Nicotine e-liquid packaging (Exhibit A) and similar candy packaging (Exhibit B) cited in an FDA warning
letter to the e-liquid manufacturer DripMore LLC, as being labelled and/or advertised in a way that is
appealing to children and targeting child consumers. (downloaded 05/22/2018 from:
https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm605938.htm)
Jpeg file of this image has been uploaded with the manuscript.
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Table S1. Multinomial logistic regression models regressing demographic and EVP-use characteristics on
adult’s perceptions of 2 different doses of EVP e-liquid nicotine in the eye causing harm to a child 6 years
and younger.
Model S1.1, In the eye contact with 2 or 3 drops
Model S1.2, In the eye contact with a
of nicotine e-liquid1,2
teaspoon or more of nicotine e-liquid1,2
Moderately Dangerous
Very Dangerous
Moderately Dangerous
Very Dangerous
OR¥ (95% CL^)
Global test of null hypothesis [F(df); p]

OR¥ (95% CL^)

1.3(14,543); .24

OR¥ (95% CL^)

OR¥ (95% CL^)

1.3(14,543); .19

EVP use status
EVP user
0.6 (0.2, 1.9)
Never-user, lives w/EVP user
1.1 (0.3, 4.0)
Never EVP-use by any adult in home
ref
Relationship with youngest child in the home
Parent or parent figure
0.9 (0.3, 2.5)
Other relative or roommate of
ref
parent
Sex
Male
0.9 (0.4, 2.1)
Female
ref
Categorical Age
18-34
1.3 (0.6, 3.1)
> 35
ref

0.4 (0.2, 1.2)
1.0 (0.3, 3.4)
ref

0.4 (0.1, 1.9)
2.5 (0.4, 15.5)
ref

0.3 (0.1, 1.0)
1.6 (0.3, 9.2)
ref

1.1 (0.4, 2.9)

1.4 (0.4, 4.6)

1.6 (0.6, 4.5)

ref

ref

ref

0.7 (0.3, 1.5)
ref

0.8 (0.3, 2.3)
ref

0.7 (0.3, 1.8)
ref

1.3 (0.6, 2.7)
ref

1.0 (0.4, 2.7)
ref

0.7 (0.3, 1.7)
ref

Abbreviations: ¥OR: odds ratio; ^CL: confidence limits.
1 The dependent variable (DV) was assessed with the question: ‘How dangerous do you think it would be for a child (6 years old or younger) if [1 or 2 drops; a
teaspoon or more] of e-liquid got in their eye?’ The reference category for the DV is ‘Not or minimally dangerous’.
2
We adjusted for race/ethnicity and highest education completed in these models. Neither of these variables was significantly associated with the dependent
variables in any of the models examined, and therefore are not included in the results table.
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Abstract
Background
United States (US) cases of childhood nicotine e-liquid (NEL) exposures have risen sharply.
Aims
To: document adults’ knowledge of NEL handling practices in homes where electronic vapor
products (EVPs) are used; examine whether reported handling practices differ based on
demographic characteristics and EVP-use status; and examine associations between harm
perceptions and handling practices.
Methods
US adults (> 18 years, n = 433) living in EVP-using homes with a child (< 6 years) completed
online surveys in April 2018 regarding NEL risk-to-children perceptions and knowledge of NEL
handling practices.
Results
While a minority of EVP-users (11.7%, 95%CL:7.6-15.8) and non-users (19.6%, 95%CL:13.625.7) perceived NEL exposures being very dangerous to children, perceiving NEL exposures as
very dangerous (versus minimally or not dangerous at all) to children was significantly
associated with always using child-proof caps (aOR:3.7, 95%CL:1.1-12.0) in multinomial
models. Also, in multinomial models, non-users (versus EVP-users) had significantly higher
odds of responding ‘I don’t know’ regarding NEL-related practices, including: child-proof caps
(aOR:3.2, 95%CL:1.3-7.7), replacing bottle cap with pouring tip (aOR:10.9, 95%CL:3.8-30.9),
and mixing NEL in their homes (aOR:12.1, 95%CL:3.5-42.2.
Discussion
While perceptions that NEL exposures are very dangerous to children were associated with
always using child-proof caps, only a minority of the sample had such perceptions. EVP nonusers have greater odds of responding they don’t know how NEL are being handled in the home.
Conclusion
Measures to improve adults’ knowledge of nicotine’s harmfulness to children may increase NEL
safe handling practices such as always use using child-proof caps on NEL containers.
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Introduction
As adults’ use of electronic vapor products (EVP) to consume nicotine has grown
significantly in the United States (US) (Bao, Xu, Lu, Snetselaar, & Wallace, 2018), so too have
unintended exposures to nicotine e-liquids (NEL) among young children (< 6 years)
(Govindarajan, Spiller, Casavant, Chounthirath, & Smith, 2018; Kamboj, Spiller, Casavant,
Chounthirath, & Smith, 2016). Despite an approximately 19% drop in reported cases of young
child exposures following national mandates for NEL child-resistant packaging (Govindarajan et
al., 2018), several hundred cases are reported monthly to US poison control centers ("Electronic
Cigarettes and Liquid Nicotine Data," 2018).
Research regarding NEL storage practices in homes of EVP users where young child(ren)
live is scant. Garbutt et al. (2015) examined this issue among parents of child patients attending
an urban US pediatrics practice; they found that 36% of their sample neither had child-proof caps
on NEL bottles, nor stored those bottles in a locked space. The most common NEL storage
spaces were in a drawer or cupboard, followed by a purse or personal bag. In addition, studies
have found that perceptions of NEL-related harm to children vary by exposure mode (Garbutt et
al., 2015; Kemp, Spears, Ashley, & Pechacek, 2018), with approximately twice the proportion of
each study’s sample characterizing NEL ingestion by a child as “very dangerous” as those who
characterized skin contact as “very dangerous.”
The present study’s design was guided by the Protection Motivation Theory (PMT)
(Prentice-Dunn & Rogers, 1986). PMT posits that the accuracy of individuals’ (i.e., adults in the
home) perceptions of the severity of and susceptibility to a threat (i.e., children being exposed to
NEL) predicts their motivation to protect against that threat (i.e. NEL safe-handling practices).
Previous research (Kemp et al., 2018) indicates that EVP-users are less likely (versus non-users)
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to perceive NEL as being very harmful to children. This study’s design also considered prior
research indicating that while adults in households with children may recognize the potential
harms of exposure to commonly used household chemicals (such as bleach), they have low
awareness and/or compliance with safe storage recommendations (Kaufman, Smolinske, &
Keswick, 2005; Smolinske & Kaufman, 2007). Thus, understanding NEL-related risk
perceptions, awareness, and practices of all adults in the home is important in determining what
measures are needed to protect children from this exposure.
Considering this conceptual framework and the paucity of evidence describing NELrelated practices in homes with young children, this pilot study sought to: 1) document adults’
knowledge of NEL handling practices in EVP-using homes where at least one child (<6 years)
lives; and 2) examine whether NEL handling practices differ based on demographic
characteristic and EVP-use status; and 3) examine relationships NEL-related between harm
perceptions and handling practices.
Methods
An online survey was conducted on the Amazon Mechanical Turk Platform (MTurk) in
April 2018 to a convenience sample of adult (> 18 years) US residents who lived in a home with
at least one child (< 6 years). These adults were either current EVP-users or had never used
EVPs but lived with a current user (non-user) was conducted. Details regarding data collection
are documented elsewhere (Kemp et al., 2018). The study protocol was reviewed by the Georgia
State University (GSU) Institutional Review Board and determined to be exempt.
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Measures
Socio-Demographic Characteristics
Demographic attributes, including sex, race/ethnicity (‘White non-Hispanic’ (NH) and
‘Black non-Hispanic, Hispanic, or Other’), age (‘18-34 years’ and ‘35 years and older’),
relationship to the youngest child (‘other relative or cohabiting’ and ‘parent or parent figure’)
residing in the home, and education (‘some college or less’ and ‘Bachelor’s degree or higher’)
were assessed.
EVP use
Adults who described another adult living with them or themselves as having used EVP
in the preceding 30 days (n = 678) were asked if the e-liquids used in their homes usually
contained nicotine. Those who answered ‘yes’ (n = 581) or ‘I don’t know’ (n = 53) were eligible
for this study; those who responded ‘no’ (n = 44) were excluded, as the study is concerning
nicotine-containing e-liquids.
Perceptions of NEL-related Harm
Participants were asked to indicate how dangerous (response options: ‘Very dangerous’,
‘Moderately dangerous’, ‘Minimally or not dangerous at all’) they thought two doses (‘1 or 2
drops’, ‘a teaspoonful or more’) of five modes (‘On the lips’, ‘In the eyes’, ‘In the nose’, ‘Skin
contact’, and ‘Swallowing’) of NEL exposure would be for a child (< 6 years). The equally
weighted scores for these items were added together, then divided by 10 to form a composite
measure of ‘NEL-related harm to children’ perceptions.
NEL Handling Practices in the Home
In the absence of existing validated measures, we consulted with tobacco control and
child safety experts in developing survey questions to assess NEL handling practices.
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Participants were asked to indicate how often the following occurred in their homes: ‘The eliquids used in my home have child-proof caps’; ‘The bottle cap is replaced with a pouring tip’,
and ‘Nicotine e-liquids are mixed in my home’. Response options included: ‘Always’,
‘Sometimes’, ‘Never’, and ‘I don’t know’.
Data Analysis
Using SAS software, version 9.4 (©2012, The SAS Institute, Cary, NC), descriptive
statistics and F tests were computed to evaluate demographic characteristics, NEL harm
perceptions, and responses regarding NEL-related practices in the home in relation to EVP-use
status. Adjusted relationships between the IVs (Demographic characteristics, EVP-use status,
and NEL-related harm perceptions) and each DV (NEL-related practices) were evaluated with
multinomial logistic regression models.
Results
The univariate and bivariate descriptive statistics (Table 1) demonstrate that EVP-users
and non-users in this sample were demographically similar in terms of race/ethnicity, age,
highest education completed, and relationship with the youngest child in the home. A
significantly larger proportion of EVP-users (p = .004) characterized children (< 6 years) being
exposed to NEL as “minimally or not dangerous at all’. A minority of EVP-users (11.7%, 95%
confidence limits (CL): 1.7-15.8) and non-users (19.6%, 95%CL: 13.6-25.7) characterized NEL
exposures as very dangerous to children. Among the overall sample (no significant intergroup
differences by EVP-use status were observed), less than half (47.4% 95%CL: 42.7, 52.2)
reported that the NEL always have child-proof caps and a third (33.7%, 95%CL: 29.2, 38.2)
reported the NEL were sometimes being mixed in their homes. Significantly larger proportions of
non-users (versus EVP-users) responded ‘I don’t know’ to all of the NEL handling practices in
the home.
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In the multinomial logistic regression models, those who perceived NEL exposures as
very dangerous (versus minimally or not dangerous at all) to children had significantly higher
odds of always using child-proof caps (aOR: 3.7, 95%CL: 1.1-12.0). Non-users (versus EVPusers) had significantly higher odds of responding ‘I don’t know’ to: whether NEL in their homes
have child-proof caps (aOR: 3.2, 95%CL: 1.3-8.0), if the NEL bottle cap is replaced with a
pouring tip (aOR: 13.0, 95%CL: 4.6-36.7); and if NEL are mixed in their homes (aOR: 9.8,
95%CL: 2.7-35.6). In addition, Black NH, Hispanic, or Other race persons (aOR: 3.0, 95%CL:
1.2-7.7) had significantly greater odds (versus White NH persons) of reporting that NEL are
always mixed in their homes.
Discussion
This foundational study examined adult EVP-users’ and non-users’ awareness of and/or
practices related to NEL in homes where young (< 6 years) children live and found important
knowledge gaps and opportunities to improve safe handling practices in homes where young
children reside. For example, only half of non-users and less than half of EVP-users reported that
the NEL containers in their homes always had child-proof caps. Approximately 34% and 44% of
EVP-users and non-users (respectively) reported that NEL are sometimes or always mixed in
their homes. A minority of respondents perceived NEL exposure as being very dangerous to
children (< 6 years). In spite of these identified gaps, respondents characterizing NEL exposure
as very dangerous to children are significantly more likely to report always having child-proof
caps on NEL containers in their homes.
These findings support the PMT-informed modelled relationship of perceiving NEL
exposures as harmful to children predicting protective behavior (NEL always having child-proof
caps) (Prentice-Dunn & Rogers, 1986) and suggests that improving adults’ knowledge of
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nicotine’s harmfulness to children could improve NEL safe-handling practices. Protecting
children from NEL exposures has been identified as a priority; a principle source of EVP-related
morbidity and mortality is NEL exposures among young children, and NEL ingestion can be
fatal (National Academies of Sciences, 2018). Nicotine’s harmfulness to children from fetal
development through adolescence is well documented in the literature (England et al., 2017;
Govindarajan et al., 2018; The health consequences of smoking – 50 years of progress: a report
of the Surgeon General, 2014; Kamboj et al., 2016).
This study also found that some EVP non-users lack awareness of NEL handling
practices in their homes. Although concerning, it highlight an opportunity to improve non-users’
NEL-related knowledge, engaging them as another line of protection against children from NEL
exposures.
Although a US Federal law enacted in 2016 requires child-proof packaging for all NEL
(Nelson, 2016), less than half of this sample reported always using child-proof caps on NEL in
their homes. Furthermore, the impact of that law has been modest (Govindarajan et al., 2018),
highlighting the importance of developing multifaceted approaches to preventing child NEL
exposures.
While evidence-based best practices for NEL handling in the home have yet to be
developed, the US Food and Drug Administration (FDA) recently published recommendations,
such as always storing NEL out of children’s reach and teaching children that only adults should
handle NEL ("Do You Vape? See These Tips on How to Keep E-Liquids Away from Children,"
2018) ("Do You Vape? See These Tips on How to Keep E-Liquids Away from Children," 2018)
to protect children from NEL exposures. Research examining consumer storage practices of
common household hazardous materials in relation to child poisoning risks in the home have
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similarly found inconsistencies, such as not always using childproof packing to store hazardous
chemicals (Kaufman et al., 2005; Smolinske & Kaufman, 2007). General evidence-based homesafety practices could protect children from NEL exposures, such as teaching parents to identify
when a hazard (i.e., NEL) is reachable and accessible to a child and developing mitigation
strategies (Guastaferro, Lutzker, Graham, Shanl, & Whitaker, 2012).
NEL-related practices in homes where young children live is an important issue; a 2018
review of EVP-focused evidence concluded that a principle source of EVP-related morbidity and
mortality is young children ingesting or absorbing (via eye or dermal contact) NEL, and
ingestion can be fatal (National Academies of Sciences, 2018). Nicotine’s potential harmfulness
to children from fetal development through adolescence is well documented in the literature
("Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act,"
2016; England et al., 2017; Govindarajan et al., 2018; Kamboj et al., 2016).
This study was limited by having no existing validated measures to evaluate NEL
handling practices in homes with children. To mitigate this concern, we consulted with subject
matter experts when developing the survey. We also requested feedback from the first 25
respondents; no concerns were raised. The generalizability of these findings are limited by the
sampling frame (MTurk). Being an exploratory study, we were not seeking representativeness;
we sought to describe adults’ EVP-related behaviors in homes where children live to identify
factors to be explored in future research.

Summary and Conclusions
NEL exposures are a principle source of EVP-related harm to American children. This
study found that a substantial proportion of adult EVP-users and non-users living with small
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children lacked adequate knowledge of NEL’s harmfulness to children and reported NEL storage
practices were inadequate to protect children from NEL exposures. Despite these gaps, this study
identified a relationship between perceiving NEL exposure as very dangerous to children and
higher odds of always using childproof caps on NEL containers. Interventions are needed to
improve adults’ knowledge of NEL’s harmfulness to children and improve safe handling
practices in homes.
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Table 1. Univariate and bivariate analyses of sample demographics and risk perceptions of children (< 6 years old) being exposed
to nicotine e-liquids at different doses and by different modes stratified by EVP use status (N = 433).
Univariate
Bivariate By EVP_USE variable
Never-user, lives
EVP user
% (95% CL*)
w/EVP user
F(df), p
% (95% CL*)
% (95% CL*)
EVP use status
N = 433
59.1 (54.5, 63.8)
40.9 (36.2, 45.5)
14.4(1,432), .0002
Socio-Demographic Characteristics
Relationship with youngest child in the
home
Parent or parent figure
Other relative or roommate of parent
Sex
Male
Female
Race/Ethnicity
White, NH
African-American, Hispanic, or Other
Categorical Age
18-34
> 35
Highest education completed
<=Some college
>= Bachelor’s
Perceptions of EVP-related Harm

0.1(1,432), .78
75.3 (71.2, 79.4)
24.7 (20.6, 28.8)

75.8 (70.5, 81.1)
24.2 (19.0, 29.5)

74.6 (68.1, 81.0)
25.4 (19.0, 31.9)

50.6 (45.8, 55.3)
49.4 (44.7, 54.2)

59.0 (52.9, 65.0)
41.0 (35.0, 47.1)

38.4 (31.2, 45.6)
61.6 (54.4, 68.8)

78.1 (74.1, 82.0)
21.9 (18.0, 25.9)

78.5 (73.5, 83.6)
21.5 (16.4, 26.5)

77.4 (71.2, 83.6)
22.6 (16.4, 28.8)

53.1 (48.4, 57.8)
46.9 (42.2, 51.6)

52.3 (46.2, 58.5)
47.7 (41.5, 53.8)

54.2 (46.9, 61.6)
45.8 (38.4, 53.1)

30.9 (26.5, 35.2)
69.1 (64.8, 73.5)

34.0 (28.2, 39.8)
66.0 (60.2, 71.8)

26.3 (19.7, 32.8)
73.7 (67.2, 80.3)

17.7(1,432), <.0001
0.1(1,432), .78
0.2(1,432), .70
2.9(1,430), .09

How dangerous for you think it would be for a child (< 6 years) to swallow or
get a few drops or a teaspoon or more of nicotine e-liquids on their skin, lips,
eyes, or nose?
Very dangerous 15.0 (11.5, 18.5)
11.7 (7.6, 15.8)
Moderately dangerous 62.2 (57.4, 66.9)
60.3 (54.0, 66.5)
Minimally or not dangerous at all 22.9 (18.8, 26.9)
28.0 (22.3, 33.8)
NEL Handling Practices in the Home
The e-liquids used in electronic vaporizer products in my home have childproof caps.
Always 47.4 (42.7, 52.2)
50.4 (44.2, 56.6)
Sometimes 28.4 (24.1, 32.7)
29.2 (23.5, 34.9)
Never
12.9 (9.7, 16.1)
13.6 (9.3, 17.9)
I don’t know
11.3 (8.3, 14.3)
6.8 (3.7, 9.9)
The bottle cap is replaced with a pouring tip.
Always
13.0 (9.8, 16.2)
12.4 (8.3, 16.6)
Sometimes 27.1 (22.9, 31.4)
31.7 (15.9, 37.5)
Never 50.0 (45.2,54.8 )
53.0 (46.8, 59.2)
I don’t know
9.9 (7.1, 12.8)
2.8 (0.7, 4.9)
Nicotine e-liquids are mixed in my home.
Always
5.9 (3.6, 8.1)
6.0 (3.1, 9.0)
Sometimes 33.7 (29.2, 38.2)
37.8 (31.7, 43.8)
Never 53.5 (48.8, 58.3)
53.8 (47.6, 60.0)
I don’t know
6.8 (4.4, 9.3)
2.4 (0.5, 4.3)

5.6(2,812),.004
19.6 (13.6, 25.7)
64.9 (57.6, 72.1)
15.5 (10.0, 21.0)

12.2(3,1275), .007
43.2 (35.8, 50.5)
27.3 (20.7, 33.9)
11.9 (7.1, 16.7)
17.6 (12.0, 23.3)
12.2(3,1269), <.0001
13.7 (8.6, 18.8)
20.6 (14.6, 26.6)
45.7 (38.3, 53.1)
20.0 (14.1, 26.0)
6.7 (3,1270), .0002
5.7 (2.3, 9.2)
28.0 (21.3, 34.7)
53.1 (45.7, 60.6)
13.1 (8.1, 18.2)

Abbreviations: EVP- Electronic Vapor Product; aOR- adjusted odds ratio; CL- confidence limits. Bolded OR indicates statistical significance at p < .05
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Table 2. Results of logistic regression models regressing demographic characteristics, current EVP use status, and risk perceptions
related to a child (< 6 years) being exposed to second-hand EVP vapor regressed on reported nicotine e-liquid and EVP-product
handling and storage practices in EVP-using homes.
Model 1

Model 2

Model 3

The e-liquids used in
EVPs in my home have
child proof caps. b,c
aOR (95% CL)

The bottle cap is
replaced with a pouring
tip. b,c
aOR (95% CL)

Nicotine e-liquids are
mixed in my home b,c
aOR (95% CL)

Always
Sometimes
I don’t know

0.8 (0.4, 1.6)
1.1 (0.5, 2.2)
3.2 (1.3, 8.0)

1.5 (0.8, 2.8)
0.8 (0.5, 1.4)
13.0 (4.6, 36.7)

1.2 (0.5, 2.9)
0.7 (0.5, 1.2)
9.8 (2.7, 35.6)

Always
Sometimes
I don’t know

0.9 (0.4, 1.7)
0.9 (0.4, 1.9)
0.7 (0.3, 1.8)

0.9 (0.5, 1.6)
1.1 (0.7, 1.9)
1.8 (0.8, 3.9)

0.9 (0.3, 2.2)
0.6 (0.4, 1.0)
0.9 (0.3, 2.3)

EVP use statusd
Non EVP-user, lives with user

Categorical agee
18-34 years

Race/ethnicityf
African-American non-Hispanic, Hispanic, multi-racial, or other
Always
0.5 (0.2, 1.1)
1.6 (0.8, 3.3)
Sometimes
0.7 (0.3, 1.5)
1.7 (0.9, 3.0)
I don’t know
0.9 (0.3, 2.4)
1.1 (0.4, 2.9)
Highest educationg
Some college or less
Always
1.5 (0.7, 3.1)
1.3 (0.6, 2.6)
Sometimes
1.2 (0.5, 2.6)
1.1 (0.6, 2.0)
I don’t know
2.1 (0.8, 5.4)
1.9 (0.8, 4.4)
Relationship to youngest child in the homeh
Other relative or cohabiting
Always
1.4 (0.7, 2.9)
0.8 (0.4, 1.6)
Sometimes
2.2 (1.0, 4.8)
0.8 (0.5, 1.4)
I don’t know
1.2 (0.5, 2.9)
0.7 (0.3, 1.6)
How dangerous for you think it would be for a child (< 6 years) to swallow or get a few drops or a
teaspoon or more of nicotine e-liquids on their skin, lips, eyes, or nose?i
Very Dangerous
Always
3.7 (1.1, 12.0)
0.8 (0.3, 2.2)
Sometimes
0.9 (0.3, 3.5)
0.5 (0.2, 1.2)
I don’t know
0.6 (0.1, 3.5)
2.1 (0.7, 6.2)
Moderately dangerous
Always
1.7 (0.8, 3.8)
0.7 (0.3, 1.6)
Sometimes
1.0 (0.5, 2.2)
0.8 (0.4, 1.4)
I don’t know
1.4 (0.5, 3.9)
0.5 (0.2, 1.3)

3.0 (1.2, 7.7)
1.1 (0.6, 1.9)
0.9 (0.3, 2.9)
0.4 (0.1, 1.4)
0.9 (0.5, 1.4)
1.9 (0.8, 4.8)
0.6 (0.2, 1.5)
1.1 (0.6, 1.9)
1.0 (0.4, 2.6)

0.3 (0.1, 1.6)
0.6 (0.3, 1.3)
4.9 (0.5, 47.5)
0.5 (0.2, 1.5)
0.7 (0.4, 1.1)
3.7 (0.4, 32.9)

Abbreviations: EVP- Electronic Vapor Product; aOR- adjusted odds ratio; CL- confidence limits. Unweighted statistics are, Bolded OR indicates statistical significance
at p < .05
b
Subjects were asked to indicate how often this occurred in their home; response options included: ‘Always’; ‘Sometimes’; ‘Never’; and ‘I don’t know’
c
The reference category for the dependent variables is ‘Never’.
d
EVP user refers to an adult (> 18 years) who has used a nicotine-containing EVP is past 30 days, EVP-user is the reference category.
e’
35 years and older’ is the reference category
f’
’White, (NH)’ is the reference category
g’
’Bachelor’s degree or higher’ is the reference category
h’
’Parent or parent figure’ is the reference category
i’
’Minimally or not dangerous at all’ is the reference category
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Chapter 5:
Summary and Conclusions
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Summary
The research carried out in this dissertation is among the first to examine adults’ risk
perceptions of NEL exposures causing harm to children. Study 1 (Chapter 2) identified
statistically significant and practically relevant associations between current use of tobacco
products and lower likelihood of perceiving nicotine as being definitely harmful when used
children less than 13 years old in a large U.S. nationally representative sample. In addition,
females were significantly more likely (versus males) and Black non-Hispanic (NH) individuals,
Hispanic individuals, and other NH individuals were significantly less likely (versus White, NH
individuals) to perceive nicotine as being definitely harmful when used by children in Study 1.
Study 2 (Chapter 3) built on this evidence by examining adults’ risk perceptions of the
danger to children (6 years and younger) being exposed to two doses of nicotine NEL (‘1 or 2
drops’ and ‘a teaspoon or more’) by five different modes (on the skin, in the eye, on the lips, in
the nose, and by swallowing), for a total of ten dose/exposure mode dyads. To my knowledge,
this is the first such study to examine specific doses in combination with specific exposure
modes. Consistent with Study 1 finding that current tobacco product users were less likely to
characterize nicotine use in children (<13 years), Study 2 found that current ENDS users who
live in a home with at least one child (< 6 years) were significantly less likely (versus adult
ENDS never-users living in never-user homes with at least one child) to perceive nicotine as
being moderately or very dangerous to children in 70% of the dose/mode dyads examined. Also
similar to Study 1, males in Study 2 were significantly less likely to perceive nicotine exposure
as being ‘very dangerous’ in some of the dose/mode dyads examined.
Study 3 (Chapter 4) built on the evidence produced in Study 2 by examining the
relationship between adults’ risk perceptions (quantified as a composite measure of the
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dose/mode risk perceptions examined in Study 2) and behaviors related to NEL handling
practices in homes where at least one adult current ENDS-user and at least one child (< 6 years)
lived. The NEL practices included using child-proof caps of NEL, replacing the NEL cap with a
pouring tip, and NEL being mixed in the home. Study 3 found that roughly half of both ENDSusers and non-users reported that the most desired practices from a child-safety point-of-view
(i.e., NEL containers always having child-proof caps, bottle caps never replaced with pouring
tips, and NEL never mixed in homes) were followed. These results indicate opportunities to
improve safe NEL handling practices in homes with children through proximal and distal-level
interventions. They also highlight the need for more research in this area to understand more
clearly how NEL and ENDS materials are being used and stored in homes with young children.
Study 3 hypothesized that perceptions of nicotine being ‘very dangerous’ would be
associated with reporting of more protective NEL practices. This hypothesis was supported, in
that subjects who perceived NEL exposure as being ‘very dangerous’ were significantly more
likely to report that NEL containers in their homes ‘always’ had child-proof caps. When
combined with the finding that only a minority of respondents (regardless of ENDS-use status)
perceived NEL exposure as being very dangerous to children (< 6 years), these results suggest that

improving adults’ knowledge of the dangers of nicotine exposure to children might increase the
likelihood of their always using childproof caps on NEL containers.
Another important finding in Study 3 is that ENDS non-users were significantly more
likely to respond that they didn’t know how NELs were handled in their homes across the three
categories of practices examined. These findings highlight an important opportunity to engage
non-ENDS-using adults in ENDS-using homes as a second-line of defense to protect children
from NEL exposures; these adults might benefit from educational interventions to alert them to
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the harms acute and chronic exposures to nicotine causes to children. While ENDS users may
have the most proximity to and control over NEL handling in the home, they also appear to
estimate lower potential risks of child NEL exposures, compared to EVP non-users. Non-users in
ENDS-using homes can provide important reinforcement of safe-handling behaviors by
advocating for, establishing, and enforcing safe handling practices in their homes. Future
research should focus on developing effective messaging and communication channels to reach
these adults; such research can be modeled on previous studies related to smoke-free home rules
to protect children in the home.107,108
The research outlined in this dissertation makes important contributions to the science of
Public Health (PH) by developing our understanding of which population subgroups are more
likely to lack adequate knowledge not only of nicotine’s harmfulness to children, but also
whether/how NEL and other nicotine products are be handled in their homes. Such knowledge is
essential in developing effective PH harm reduction interventions. For example, this research
identified statistical relationships between current tobacco product use and lower odds of
perceiving nicotine as harmful to children in general. Then it more specifically, and perhaps
more importantly, identified relationships linking current ENDS-use status to risk perceptions of
NEL exposures being harmful to children. The knowledge that tobacco product users generally
and ENDS-users specifically are less likely to appreciate how harmful nicotine exposure is to
children indicates a need to educate these product users about nicotine-specific harms to children
and their responsibility to prevent children from being exposed to nicotine-containing products.
Another important example of how this research contributes to PH science is the finding
that ENDS non-users living with ENDS-users are significantly more likely to indicate that they
lack knowledge of NEL handling practices in their homes. Non-users can play an important role
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in protecting children from NEL exposure in their homes. PH messaging educating them of
NEL’s harmfulness to children in their homes, what the different products look like, and
suggested handling rules (i.e., ‘Always ensure NEL in your home has childproof packaging’;
‘Never allow a child to handle NEL or ENDS devices’; ‘If a child is exposed to NEL, seek
immediate medical attention’; etc.) to be enforced in their homes. Furthermore, messaging
regarding NEL handling in the home could also be framed in the context of being handled the
way other child hazards (such as prescription drugs, cleaning chemicals, solvents, etc.) are
managed, to reinforce the seriousness of child nicotine toxicity.
Conclusions
Future research is needed to replicate the findings of Study 2 and Study 3 in larger, more
representative samples of adults to confirm and further explicate these findings. Children have
been identified as a priority population by the Surgeon General55 in an effort to reduce tobacco
product-related harms. ENDS-use research has focused almost exclusively on factors associated
with intended use. Despite the growing incidence of adverse clinical events resulting from
children’s exposures to NEL and the evidence indicating that ENDS use is growing fastest
among young adults (in their child-bearing years), there is a paucity of research examining
adults’ risk perceptions or factors associated with children’s exposure. In documenting adults’
knowledge gaps related to and risk perceptions of child NEL exposures, the research described in
this dissertation makes important and novel contributions to Tobacco Regulatory Science. Future
research is needed to confirm these findings and further explore child safety issues related to
nicotine and NEL exposures.
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Appendix 1, Study 1 questions for variables extracted from TCORS Annual Survey data
Variable Name

Survey Question

Response Options

NTHMCHLD

[Children (under 13 years old)] Most tobacco
products, including most electronic vapor
products, contain nicotine. When used by the
following groups, how harmful is nicotine in
amounts usually found in tobacco products?

PPAGECT4

Categorical Age

PPEDUCAT

Categorical education

PPGENDER

Gender

0 = 'Not harmful'
1 = 'Unlikely harmful'
2 = 'Maybe harmful'
3 = 'Definitely harmful'
9 = 'Don’t know'
1 = '18-29'
2 = '30-44'
3 = '45-59'
4 = '60+'
1 = 'Less than high school'
2 = 'High school'
3 = 'Some college'
4 = 'Bachelor’s degree or
higher'
1 = 'Male'
2 = 'Female'
1 = 'White, Non-Hispanic'
2 = 'Black, Non-Hispanic'
3 = 'Hispanic'
4 = Other or'2+ Races, NonHispanic'

RACE

Race/Ethnicity

CGEV100

Have you smoked at least 100 cigarettes in
your entire life? One hundred cigarettes is
equal to 5 packs.

CGNOW

Do you now smoke cigarettes every day,
some days, or not at all?

ECEVER

Have you ever used electronic vapor
products, even one or two times?

ECNOW

Do you now use electronic vapor products
every day, some days, rarely, or not at all?

TCEVER

Have you ever smoked traditional cigars,
even one or two puffs?

TCNOW

Do you now smoke traditional cigars every
day, some days, rarely, or not at all?

0 = 'No'
1 = 'Yes’
0 = 'Not at all'
1 = 'Some days'
2 = 'Every day
0 = 'No'
1 = 'Yes’
0 = 'Not at all'
1 = 'Rarely'
2 = 'Some days'
3 = 'Every day'
0 = 'No'
1 = 'Yes’
0 = 'Not at all'
1 = 'Rarely'
2 = 'Some days'
3 = 'Every day'
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LCEVER

Have you ever smoked little cigars, cigarillos,
or filtered cigars, even one or two puffs?

LCNOW

Do you now use little cigars, cigarillos, or
filtered cigars every day, some days, rarely,
or not at all?

HKEVER

Have you ever used hookahs, even one or
two puffs?

HKNOW

Do you now use hookahs every day, some
days, rarely, or not at all?

FAMILY

COMBUST

VAPER
NCUSE30

TOBPROD

Calculated variable, combining variables
related to how many children in the home in
specific age ranges (PPT01, PPT25, PPT612,
PPT1317) to reflect whether or not there is at
least 1 minor child in the home.
Calculated variable to reflect current use of
at least 1 combusted tobacco product
(DOV_Smoker, TCEVER, TCNOW, LCEVER,
LCNOW, HKEVER, HKNOW)
Computed variable to reflect current use of
vaporized tobacco product using electronic
nicotine delivery system (ECEVER, ECNOW)
In the past 30 days, have you used any of the
following: chewing tobacco, dip or snuff,
snus, or dissolvable tobacco?
Computed variable to reflect current use of a
combusted, vaporized and/or noncombusted tobacco product

0 = 'No'
1 = 'Yes’
0 = 'Not at all'
1 = 'Rarely'
2 = 'Some days'
3 = 'Every day'
0 = 'No'
1 = 'Yes’
0 = 'Not at all'
1 = 'Rarely'
2 = 'Some days'
3 = 'Every day'
0 = 'No'
1 = 'Yes’

0 = 'No'
1 = 'Yes’
0 = 'No'
1 = 'Yes’
0 = 'No'
1 = 'Yes’
0 = 'No tobacco products
currently used'
1 = '1 tobacco product
currently used'
2 = '2 or more tobacco
products currently used'
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Appendix 2, Survey instrument developed in Qualtrics, administered on MTurk April 3-4, 2018 for Study 2
and Study 3
P-CRAINS Survey Instrument, revised 03/07/2018
Start of Block: Informed Consent
IC_00 Thank you for your interest in our study. We begin by asking for your agreement to participate, followed by several questions to determine if you qualify for
participation.
IC_01 Georgia State University School of Public Health
Title:
Principal Investigator:
Student Principle Investigator:
Co-Investigator:
Sponsor:
I.

II.

III.
IV.
V.
VI.

VII.

VIII.

IX.

Informed Consent
Adults’ perceptions of risks associated with children ingesting nicotine e-liquids
Terry F. Pechacek, Ph.D.
Catherine B. Kemp, BSN, MHA, Ph.D. Candidate
Claire A. Spears, Ph.D.
National Institutes of Health (NIH), Food and Drug Administration (FDA)

Purpose: We invite you to take part in a research study, led by Catherine Kemp, a Ph.D. candidate in the School of Public Health at Georgia State University,
and her academic adviser, Dr. Terry Pechacek. We are doing this study to understand more about what adults think and know about children being
exposed to the nicotine liquids used in electronic vaping devices like e-cigarettes. We would also like to learn more about how these materials are used
and stored in people’s houses. We are asking adults 18 years old and older who have at least one child (under 18 years old) living in their home and
either: use electronic cigarettes or electronic vaping devices, live in a home with someone who uses electronic cigarettes or electronic vaping devices, or
live in a home where no-one uses electronic cigarettes or electronic vaping devices to take part in this study. The rest of this consent form we will call
these devices as ‘EVP’ (which stands for “electronic vaping products”) and the nicotine liquids used in them as ‘e-liquids’. Please read this whole form;
it will tell you everything you need to think about before you decide to agree to be in the study or not.
Procedures: First we will ask you some questions to make sure you are eligible. If you are not eligible, you will not be able to complete the survey and will
not be paid for responding to the screening questions. If you are eligible, we will ask you about your opinions on the effects these liquids and devices
might have on children who are exposed to them. For people who use EVPs or live in a house where another adult uses EVPs, we will also ask about how
EVPs are used and stored in your home. We think that it will take about 15 minutes to complete the survey. To learn more about cutting back on or quitting
tobacco product use, contact the National Tobacco Quit Line at 1-877-44U-QUIT (1-877-448-7848).
Risks: First, there are privacy risks to completing surveys online because data sent over the Internet may not be secure. To reduce this risk, we will not ask
you for any information that could identify you personally and we will store your answers to questions on a secure server. Second, it is possible that you
may feel uncomfortable answering some of the questions. You are welcome to skip any questions that you don’t want to answer.
Benefits: You may not benefit personally from taking part in this study. Overall, we hope to learn about your opinions and practices related to the handling
and storage of EVPs to help the Food and Drug Administration and National Institutes of Health in developing policies to protect the public’s health.
Compensation: You will complete the study using a computer over the Internet. Once you complete the survey, you will receive payment from MTurk worth
$2.00. Please know that taking the survey is voluntary. You will still get your incentive even if you skip some questions, but you do have to go to the end
of the survey to receive the $2.00 payment.
Voluntary Participation and Withdrawal: Taking part in this research is voluntary. You do not have to be in this study. If you decide to be in the study and
change your mind, you have the right to drop out at any time. You may skip questions or withdraw from the study at any time. Whatever you decide, you
will not lose any benefits to which you are otherwise entitled.
Confidentiality: We will keep the responses you provide private to the extent allowed by law. We are not asking for your name or other facts that could be
used to identify you. The findings will be pooled and reported in group form. Only the study’s Principal Investigator, Ms. Kemp, and project staff will have
access to the answers you give, which will be stored in a locked folder on a firewall-protected computer that is on a secure server. Only the Principal
Investigator and project staff will have access to these data. Study responses might be shared with those who make sure the study is done correctly (GSU
Institutional Review Board, and the National Institutes of Health and the Food and Drug Administration, the study sponsors). We plan to share the results
of the study with other researchers, in papers, and at conferences.
Contact Persons: Contact Catherine Kemp at (404) 413-1142 or ckemp9@student.gsu.edu if you have questions, concerns, or complaints about this study.
You can also call if you think you have been harmed by the study. Call Susan Vogtner in the Georgia State University Office of Research Integrity at 404413-3513 or svogtner1@gsu.edu if you want to talk to someone who is not part of the study team. You can talk about questions, concerns, give
suggestions, or learn more about the study. You can also call Susan Vogtner if you have questions or concerns about your rights in this
study.
Copy of Consent Form to Participant: If you would like a copy of this consent form, please print it from this screen before going to the next screen. If you
agree to participate in this research, please click the CONTINUE button.

o
o

CONTINUE, I have read the information above and I agree to participate in this study (1)
EXIT, I have read the information above and I DO NOT agree to participate in this study (2)

Skip To: End of Block If Georgia State University School of Public Health Informed Consent Title: Adults’ perceptions... = CONTINUE, I have read the information
above and I agree to participate in this study
Skip To: End of Survey If Georgia State University School of Public Health Informed Consent Title: Adults’ perceptions... = EXIT, I have read the information above
and I DO NOT agree to participate in this study
End of Block: Informed Consent
Start of Block: Screening Questions
SC_00 Screening/inclusion criteria
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Page Break
SC_01 What is your age (in years) as of your last birthday?
Click to write Label 1
15

21

28

34

40

46

53

59

65

71

75

(1)

Skip To: EXCLUDED If What is your age (in years) as of your last birthday? <
Skip To: SC_02 If What is your age (in years) as of your last birthday? >=
SC_02 Using numbers, please enter the year you were born in the box below, using 4 digits.
For example, if you were born in 1988, enter 1988 in the box.

o

Year (YYYY) (1) ________________________________________________

Skip To: EXCLUDED If Using numbers, please enter the year you were born in the box below, using 4 digits. For example... >= Year (YYYY)
Page Break
Sec.II EVP USE We’d like to ask about electronic vapor products (such as e-cigarettes, e-cigars, e-hookahs, e-pipes, vape pens, hookah pens, and personal
vaporizers/mods), and the liquids used in them.
Electronic vapor products are battery-powered and usually contain e-liquid (that may or may not contain nicotine) that is heated into a vapor or mist and inhaled.
Some can be bought as one-time use, disposable products, while others are reusable with a rechargeable battery and a cartridge or refillable tank system.
For the remainder of this survey, we will refer to using the devices as 'vape' or 'vaping', and the liquids used in them as 'e-liquids'.
The picture below illustrates how these devices (left) and e-liquids (right) might appear. (Pictures taken from: http://www.photosforclass.com/search/vape)

Page Break
ECAWARE Have you ever seen or heard of any type of electronic vapor product, such as e-cigarettes, e-cigars, e-hookahs, e-pipes, vape pens, hookah pens or
personal vaporizers/mods before this study?

o
o

Yes (1)
No (2)

Skip To: EXCLUDED If Have you ever seen or heard of any type of electronic vapor product, such as e-cigarettes, e-ciga... = No

100

Page Break
SC_03 Please read all options and choose the statement below that best describes use of electronic vapor products by adults who live in your home, including
yourself.

▢
▢
▢
▢
▢
▢

I have used electronic vapor products at least once in the past month. (1)

Another adult who lives with me has used electronic vapor products at least once in the past month. (2)

Both I and another adult who lives with me have used electronic vapor products at least once in the past month (3)

I have used electronic vapor products in the past, but not in the past month. (4)

Another adult who lives with me has used electronic vapor products in the past, but not in the past month. (5)

Neither I nor any other adult who lives with me has ever used electronic vapor products. (6)
Skip To: EXCLUDED If Please read all options and choose the statement below that best describes use of electronic vapo... = I have used electronic vapor products in
the past, but not in the past month.
Skip To: EXCLUDED If Please read all options and choose the statement below that best describes use of electronic vapo... = Another adult who lives with me has
used electronic vapor products in the past, but not in the past month.
Page Break
Display This Question:
If Please read all options and choose the statement below that best describes use of electronic vapo... = I have used electronic vapor products at least once in
the past month.
And Please read all options and choose the statement below that best describes use of electronic vapo... = Another adult who lives with me has used electronic
vapor products at least once in the past month.
And Please read all options and choose the statement below that best describes use of electronic vapo... = Both I and another adult who lives with me have
used electronic vapor products at least once in the past month
SC_ECFRQ30 On approximately how many of the past 30 days have electronic vapor products been used by you or another adult who lives in your home?
0
5
10
15
20
25
30
Days (1)

Skip To: EXCLUDED If On approximately how many of the past 30 days have electronic vapor products been used by you or... = Days
SC-NIC Do the e-liquids that are vaped in electronic vapor products in your home usually contain nicotine?

o
o
o

Yes (1)
No (2)

I don't know (3)
Skip To: EXCLUDED If Do the e-liquids that are vaped in electronic vapor products in your home usually contain nicotine? = No
Page Break
SC_Child_01 How many children who are 6 years old or younger live in in your household, whether or not you are their parent or guardian?
▼ 0 (1) ... 10 or more (11)
Skip To: EXCLUDED If How many children who are 6 years old or younger live in in your household, whether or not you ar... = 0
SC_Child_02 Please indicate the age of the youngest child who lives in your household (whether or not you are their parent or guardian)
0 1 2 3 4 5 6 7 8 9 9 10 11 12 13 14 15 16 17
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Age of youngest child in the home (1)

Skip To: End of Survey If Please indicate the age of the youngest child who lives in your household (whether or not you are... > Age of youngest child in the home
Display This Question:
If Please indicate the age of the youngest child who lives in your household (whether or not you are... [ Age of youngest child in the home ] <= 6
SC_Child_03 What is your relationship to the youngest child who lives in your home?

o
o
o
o
o
o
o
o

Biological parent (1)
Step-parent (2)
Grandparent (3)
Aunt or uncle (4)
Sibling (5)
Domestic partner of child's parent (not married) or primary caregiver (6)
Roommate of child's parent or primary caregiver (7)
Other (8)

Display This Question:
If What is your relationship to the youngest child who lives in your home? = Other
SC_Child_03a Briefly describe your relationship to the child(ren) living in your home
________________________________________________________________
Page Break
Display This Question:
If Please indicate the age of the youngest child who lives in your household (whether or not you are... [ Age of youngest child in the home ] > 1
SC_Child_04 Of how many of the children in your household are you the parent, step-parent, or guardian?
0
1
2
3
4
5
6
7
8
9
10
Child 1 (1)

Page Break
SC_GENDER What is your gender?

o
o

Male (1)
Female (2)

Page Break
SC_08 What is your racial/ethnic background?
▼ White, non-Hispanic (1) ... Other (5)
Display This Question:
If What is your racial/ethnic background? = Other
Q107 Briefly describe your racial/ethnic background.
________________________________________________________________
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Page Break
SC_11 Including you, how many adults (people 18 years old or older) live in your household?
▼ 1 (1) ... 10 or more (10)
Page Break
SC_EDU What is the highest level of education you've completed as of today?
▼ Less than high school (1) ... Professional degree or Doctorate (6)

Page Break
SC_INC What is your household's average yearly (annual) income?
▼ Less than $25,000 (1) ... Over $100,00 (4)

Page Break
SC_09 In what region of the country do you live?
▼ Northeast (CT, DC, DE, MA, MD, ME, NH, NJ, NY, PA, RI, VT) (1) ... Puerto Rico, Guam, U.S. Virgin Islands, or other US territories (6)

Page Break
EXCLUDED Thank you for your interest in our study. We are looking for people with specific characteristics to include in the study. Based on the responses you've
provided, you either do not meet these criteria or we already have the number of responses needed from people who have these characteristics.
Please click the "Exit" button below to exit the survey or close this window in your browser.

o

Exit (1)
Skip To: End of Survey If Thank you for your interest in our study. We are looking for people with specific characteristics... = Exit
End of Block: Screening Questions
Start of Block: Risk perceptions-children's exposure, (adapted from Garbutt study)
NEL_00 The next set of question are related to your knowledge and opinions of the risks to a child (6 years old or younger) of different kinds of exposure to nicotine
e-liquids used in EVPs, such as e-cigarettes, e-cigars, e-hookahs, e-pipes, vape pens, hookah pens and personal vaporizers/mods.
For these questions "vapor" refers to the steam from an EVP, and "e-liquids" refers to vaping liquids that contain nicotine.

Page Break
NEL_02 How dangerous do you think skin contact with one or two drops of e-liquid is for a child (6 years old or younger)?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)

I don't know (5)
Page Break
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NEL_03 How dangerous do you think skin contact with a teaspoon or more of e-liquid is for a child (6 years old or younger)?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_04 How dangerous do you think it would be for a child (6 years old or younger) if one or two drops of e-liquid got on their lips, in their nose, or in their eyes?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_05
How dangerous do you think it would be for a child (6 years old or younger) if a teaspoon or more of e-liquid got on their lips, in their nose, or in their eyes?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_06 How dangerous do you think it would be for a child (6 years old or younger) if they swallowed one or two drops of e-liquid?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_07 How dangerous do you it would be for a child (6 years old or younger) if they swallowed a teaspoonful or more of e-liquid?
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o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_08 How dangerous do you think it is for a child (6 years old or younger) to inhale the vapor directly from an EVP?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_09 How dangerous do you think is for a child (6 years old or younger) to inhale the second-hand vapor from another person using an EVP?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_10 How dangerous do you think is for a child (6 years old or younger) to inhale smoke directly from a cigarette?

o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_11 How dangerous do you think is for a child (6 years old or younger) to inhale the second-hand smoke from another person smoking a cigarette?
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o
o
o
o
o

Very dangerous (1)
Moderately dangerous (2)
Minimally dangerous (3)
Not dangerous at all (4)
I don't know (5)

Page Break
NEL_12 Compared to inhaling smoke directly from a cigarette, how dangerous do you think is for a child (6 years old or younger) to inhale the vapor directly from
an EVP?

o
o
o
o
o
o

Much more dangerous (1)
Somewhat more dangerous (2)
About the same (3)
Somewhat less dangerous (4)
Not dangerous at all (5)
I don't know (6)

Page Break
NEL_13 Compared to inhaling second-hand smoke from a cigarette, how dangerous do you think is for a child (6 years old or younger) to inhale the second-hand
vapor from another person using an EVP?

o
o
o
o
o
o

Much more dangerous (1)
Somewhat more dangerous (2)
About the same (3)
Somewhat less dangerous (4)
Not dangerous at all (5)
I don't know (6)

Page Break
Q133 How much is the following statement true for you?
I am always courteous, even to people who are disagreeable.

o
o
o
o

Definitely true (1)
Mostly true (2)
I don't know (3)
Mostly false (4)
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o

Definitely false (5)

Page Break
Q134 How much is the following statement true for you?
There have been occasions when I took advantage of someone.

o
o
o
o
o

Definitely true (1)
Mostly true (2)
I don't know (3)
Mostly false (4)
Definitely false (5)

Page Break
Q135 How much is the following statement true for you?
I sometimes try to get even rather than forgive and forget.

o
o
o
o
o

Definitely true (1)
Mostly true (2)
I don't know (3)
Mostly false (4)
Definitely false (5)

Q136 How much is the following statement true for you?
I sometimes feel resentful when I don't get my way.

o
o
o
o
o

Definitely true (1)
Mostly true (2)
I don't know (3)
Mostly false (4)
Definitely false (5)

Q137 How much is the following statement true for you?
No matter who I'm talking to, I'm always a good listener.

o
o

Definitely true (1)
Mostly true (2)

107

o
o
o

I don't know (3)
Mostly false (4)
Definitely false (5)

End of Block: Risk perceptions-children's exposure, (adapted from Garbutt study)
Start of Block: EVP Risk Perceptions
VAPE_00 Please indicate how strongly you agree or disagree with the following statements
Strongly
agree (1)

o
o
o
o
o
o

Vaping is addictive. (1)

Compared to smoking cigarettes, vaping is less addictive. (2)

Vaping is safe for the health of adults who vape. (3)

Being exposed to someone else's vaping is safe for adults. (4)

Being exposed to someone else's vaping is safe for children. (5)

Seeing adults vaping could influence a child to start vaping. (6)

Somewhat
agree (2)

o
o
o
o
o
o

Neither agree
nor disagree
(3)

o
o
o
o
o
o

Strongly
disagree
(5)

Somewhat
disagree (4)

o
o
o
o
o
o

o
o
o
o
o
o

Page Break
End of Block: EVP Risk Perceptions
Start of Block: Actual Nicotine Exposures
Display This Question:
If Please read all options and choose the statement below that best describes use of electronic vapo... != Neither I nor any other adult who lives with me has
ever used electronic vapor products.

NEL_15_X
Now we'd like to ask you about how nicotine containing e-liquids and electronic vapor products are handled and stored in your home.

The e-liquids used in electronic vaporizer products in my home
have child-proof caps. (1)

o

The e-liquids used in electronic vaporizer products in my home
are stored in a designated place. (2)

o

The e-liquid used in electronic vaporizer products in my home are
kept out of reach of children. (3)

o

Always

Always

Always

o
o
o

Sometimes

Sometimes

Sometimes

o
o
o

Never

o

Never

o

Never

o

I don't
know

I don't
know

I don't
know
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We enforce rules in our house regarding the handling of the eliquid used in electronic vaporizer products in my home. (4)

o

We enforce rules in our house regarding the storage of the eliquid used in electronic vaporizer products in my home. (5)

o

The children who live with me are told they should not handle the
e-liquid used in electronic vaporizer products in my home. (6)

o

The children who live with me see adults handling electronic
vaping products in my home. (7)

o

The children who live with me are allowed to handle electronic
vaping products in my home. (8)

o

The children who live with me see adults using electronic vaping
products in my home. (9)

o

Bottles of nicotine e-liquids are left uncapped. (10)

o

Nicotine e-liquids are mixed in my home. (11)

o

The nicotine e-liquid packaging is brightly colored. (12)

o

The nicotine e-liquid packaging has pictures on it. (13)

o

The bottle cap is replaced with a pouring tip. (14)

o

Nicotine e-liquid is stored in a designated place out-of-reach of
children. (15)

o

Always

Always

Always

Always

Always

Always

Always

Always

Always

Always

Always

Always

o
o
o
o
o
o
o
o
o
o
o
o

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

o

Sometimes

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

Never

o

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

I don't
know

End of Block: Actual Nicotine Exposures
Start of Block: NicExB_00
NicExA_01-4 The next set of questions are regarding child(ren) living in your home actually being exposed to nicotine e-liquids.
Select one
Yes (1)

A child in my home has touched or held a nicotine e-liquid container. (1)

A child in my home has ingested nicotine e-liquid. (2)

o
o

No (2)

o
o

I don't know
(3)

o
o
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An adult has sought information from a poison control website, telephone helpline, and/or healthcare professional
because a child in my home was exposed to nicotine e-liquid. (3)
A child in my home has had medical attention due to nicotine e-liquid exposure. (4)

o
o

o
o

o
o

Page Break
NicExA_05 If a child(ren) living in your home was actually exposed to nicotine e-liquids, what would be your first response?

o
o
o
o
o
o
o
o

Nothing (1)
Call 911 (2)
Call the local Poison Control Hotline (3)
Search the Internet for information on what to do (4)
Watch the child for symptoms of toxicity or illness (5)
Call the child's primary healthcare provider (6)
Take the child to their doctor's office (7)
Take the child to a walk-in clinic or emergency room (8)

Page Break
End of Block: NicExB_00
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